TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T85943	Proto-oncogene c-Src	D0AZ3C	Imatinib	Approved	5291	C29H31N7O	493.6	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0B0AX	HIF-1alpha	Phase 4	5328127	C20H24N6O3	396.4	CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=CC(=CC(=C3)OC)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0I6VU	Enzastaurin	Phase 3	176167	C32H29N5O2	515.6	CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0M9QZ	ABT-869	Phase 3	11485656	C21H18FN5O	375.4	CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0L4FS	Genistein	Phase 2	5280961	C15H10O5	270.24	C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O	IC50 = 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0W3LI	LY333531	Phase 2	153999	C28H28N4O3	468.5	CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0HO1S	CGP-53353	Terminated	6711154	C20H13F2N3O2	365.3	C1=CC(=CC=C1NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)F)F	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B03GZB	3-(3,4-Dichlorophenyl)-2-(4-methoxyphenyl)-6,7-dihydro-5H-indazol-4-one	Investigative	57402054	C20H16Cl2N2O2	387.3	COC1=CC=C(C=C1)N2C(=C3C(=N2)CCCC3=O)C4=CC(=C(C=C4)Cl)Cl	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B03WBA	4-[5-Amino-4-(4-fluorophenyl)-3-pyridin-4-ylpyrazol-1-yl]benzonitrile	Investigative	56951005	C21H14FN5	355.4	C1=CC(=CC=C1C#N)N2C(=C(C(=N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B04BQN	3-[1-(1-Benzyl-piperidin-4-yl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-pyrrole-2,5-dione	Investigative	9958125	C33H30N4O2	514.6	CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=C7	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B06KZV	1,2,4-Oxadiazole Analogue 12b	Investigative	5329220	C22H23Cl2N4O8P	573.3	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CO)C2=NC(=NO2)CC3=CC(=C(C=C3)Cl)Cl	IC50 = 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	B06OYI	(S)-4-[(S)-2-((2S,3S)-2-Amino-3-methyl-pentanoylamino)-4-carboxy-butyrylamino]-4-[(S)-1-carboxy-2-(4-hydroxy-phenyl)-ethylcarbamoyl]-butyric acid	Investigative	11376301	C25H36N4O10	552.6	CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B07WMJ	3-(3,4-Dichlorophenyl)-6,6-dimethyl-2-(4-methylphenyl)-5,7-dihydroindazol-4-one	Investigative	57403801	C22H20Cl2N2O	399.3	CC1=CC=C(C=C1)N2C(=C3C(=N2)CC(CC3=O)(C)C)C4=CC(=C(C=C4)Cl)Cl	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B08AYZ	3-{[2-(3-Thienyl)pyridin-4-yl]amino}-4-{[(1R)-1-phenylethyl]amino}cyclobut-3-ene-1,2-dione	Investigative	44575127	C21H17N3O2S	375.4	C[C@H](C1=CC=CC=C1)NC2=C(C(=O)C2=O)NC3=CC(=NC=C3)C4=CSC=C4	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0E1UM	Pyrido[2,3-d]pyrimidin-7(8H)-one deriv. 6d	Investigative	5328732	C20H23Cl2N5O	420.3	CCN(CC)CCNC1=NC=C2C=C(C(=O)N(C2=N1)C)C3=C(C=CC=C3Cl)Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0EDU6	Dithiobis(1H-indole-3-alkanoic acid) deriv. 27	Investigative	5328558	C22H20N2O4S2	440.5	C1=CC=C2C(=C1)C(=C(N2)SSC3=C(C4=CC=CC=C4N3)CCC(=O)O)CCC(=O)O	IC50 = 51000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0EK6Z	1-[2-Amino-6-(3,5-dimethylphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea	Investigative	5329121	C20H24N6O	364.4	CC1=CC(=CC(=C1)C2=C(N=C3C(=C2)C=NC(=N3)N)NC(=O)NC(C)(C)C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0GO5R	4-[[[3-Acetyl-4-(cyclohexylmethoxy)benzyl]amino]carbonyl]phenylphosphate	Investigative	44305333	C23H28NO7P	461.4	CC(=O)C1=C(C=CC(=C1)CNC(=O)C2=CC=C(C=C2)OP(=O)(O)O)OCC3CCCCC3	IC50 = 69000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0H9IG	Ethyl 1-[3-oxo-3-(4-phenylmethoxyphenyl)propyl]piperidine-4-carboxylate;hydrochloride	Investigative	45260866	C24H30ClNO4	431.9	CCOC(=O)C1CCN(CC1)CCC(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0HN9A	3-(3,4-Dichlorophenyl)-6,6-dimethyl-2-(1H-pyrrol-2-yl)-5,7-dihydroindazol-4-one	Investigative	57403802	C19H17Cl2N3O	374.3	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CN4)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0HNO1	N-[2-Amino-3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-7-yl]-2,2,2-trifluoroacetamide	Investigative	5329002	C18H15F3N4O3	392.3	COC1=CC(=CC(=C1)C2=C(N=C3C=C(N=CC3=C2)NC(=O)C(F)(F)F)N)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0MK9C	(2S)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-3-(1H-indol-3-yl)propanoic acid	Investigative	71625332	C85H112N20O11	1589.9	C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC7=CNC8=CC=CC=C87)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC9=CNC1=CC=CC=C19)C(=O)O)NC(=O)[C@H](CCCCN)N	IC50 = 69100 nM	Poor binder
T85943	Proto-oncogene c-Src	B0MUO3	2,3,7,8-Tetrahydroxy-5-[(4-nitrophenyl)methyl]phenanthridin-6-one	Investigative	5328658	C20H14N2O7	394.3	C1=CC(=CC=C1CN2C3=CC(=C(C=C3C4=C(C2=O)C(=C(C=C4)O)O)O)O)[N+](=O)[O-]	IC50 = 61000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0NTO4	(6,7,8,9-Tetrahydro-5H-pyrimido[4,5-b]indol-4-yl)-m-tolyl-amine	Investigative	10660240	C17H18N4	278.35	CC1=CC(=CC=C1)NC2=NC=NC3=C2C4=C(N3)CCCC4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0NU2W	1,2,4-Oxadiazole Analogue 14d	Investigative	6326462	C30H30F3N4O8P	662.5	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)CC4=CC=C(C=C4)OC	IC50 = 87000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0OH3X	5-Butoxy-1-phenylbenzimidazole	Investigative	5328500	C17H18N2O	266.34	CCCCOC1=CC2=C(C=C1)N(C=N2)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0Q3NC	3-(Dimethylamino)-1-(3-hydroxy-4-phenylmethoxyphenyl)propan-1-one;hydrochloride	Investigative	45260879	C18H22ClNO3	335.8	CN(C)CCC(=O)C1=CC(=C(C=C1)OCC2=CC=CC=C2)O.Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0R3LI	1-Methyl-2-methylsulfanyl-N-phenylindole-3-carboxamide	Investigative	5328622	C17H16N2OS	296.4	CN1C2=CC=CC=C2C(=C1SC)C(=O)NC3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0UJ3V	(3-Bromo-phenyl)-(6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-4-yl)-amine	Investigative	10569366	C16H15BrN4	343.22	C1CCC2=C(C1)C3=C(N2)N=CN=C3NC4=CC(=CC=C4)Br	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0UXI9	(2S)-2-[[(2S)-2-[[(3S,6S,9R,20S)-6-[(2S)-Butan-2-yl]-3-[(4-hydroxyphenyl)methyl]-2,5,8,11,14-pentaoxo-9-(sulfanylmethyl)-1,4,7,10,15-pentazacycloicosane-20-carbonyl]amino]-3-(4-nitrophenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	11643703	C46H58N8O13S	963.1	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCNC(=O)CCC(=O)N[C@H](C(=O)N1)CS)C(=O)N[C@@H](CC2=CC=C(C=C2)[N+](=O)[O-])C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)CC4=CC=C(C=C4)O	IC50 = 134000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0WLH8	N-(7-Methoxyquinolin-6-yl)thieno[3,2-d]pyrimidine-7-carboxamide	Investigative	58056356	C17H12N4O2S	336.4	COC1=C(C=C2C=CC=NC2=C1)NC(=O)C3=CSC4=CN=CN=C43	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0YBG3	7-(3,5-Dimethoxyphenyl)-N-(2,5-dimethylphenyl)-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	59837646	C24H24N4O2	400.5	CC1=CC(=C(C=C1)C)NC2=NC3=C(C=C(C=C3C)C4=CC(=CC(=C4)OC)OC)N=N2	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B0ZE2B	PD089828 analog 31	Investigative	5329133	C22H30N8O	422.5	CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=CC(=CC(=C3)N(C)C)N(C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B13SUI	1-Phenyl-1H-benzimidazole-5-thiol	Investigative	5328513	C13H10N2S	226.3	C1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)S	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B19WYH	PD158780 Analog 5h	Investigative	5328354	C17H19BrN6	387.3	CN(C)CCNC1=NC=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1A4EI	(8S,16S)-3,16-Dihydroxy-9,10-seco-1,3,5(10)-cholestatrien-9-one	Investigative	9547398	C27H42O3	414.6	CC1=C(C=C(C=C1)O)CC[C@H]2[C@@H]3C[C@@H]([C@@H]([C@]3(CCC2=O)C)[C@H](C)CCCC(C)C)O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1AK9I	N-{1-[3-(3,4-Dichloro-benzyl)-[1,2,4]oxadiazol-5-yl]-ethyl}-3-(4-phosphonooxy-benzyl)-succinamic acid	Investigative	10347718	C22H22Cl2N3O8P	558.3	C[C@@H](C1=NC(=NO1)CC2=CC(=C(C=C2)Cl)Cl)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)CC(=O)O	IC50 = 53000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1BD8S	2-Fluoro-N'-[2-(1H-indol-3-yl)-2-oxoacetyl]benzohydrazide	Investigative	53328318	C17H12FN3O3	325.29	C1=CC=C2C(=C1)C(=CN2)C(=O)C(=O)NNC(=O)C3=CC=CC=C3F	IC50 = 96000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1BDN3	3-(3-Chloro-4-methylphenyl)-2-(4-chlorophenyl)-6,6-dimethyl-5,7-dihydroindazol-4-one	Investigative	57401981	C22H20Cl2N2O	399.3	CC1=C(C=C(C=C1)C2=C3C(=NN2C4=CC=C(C=C4)Cl)CC(CC3=O)(C)C)Cl	IC50 = 131800 nM	Poor binder
T85943	Proto-oncogene c-Src	B1CD9Y	Dithiobis(1H-indole-3-carboxamide) deriv. 10p	Investigative	5328607	C32H24Cl2N4O2S2	631.6	CN1C2=C(C=CC(=C2)Cl)C(=C1SSC3=C(C4=C(N3C)C=C(C=C4)Cl)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1D7YN	1,2,4-Oxadiazole Analogue 5b	Investigative	6326455	C22H24ClN4O7P	522.9	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)Cl)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 66000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1DK5Q	[4-((S)-2-Acetylamino-2-{(S)-1-[(3-cyclohexyl-propyl)-methyl-carbamoyl]-propylcarbamoyl}-ethyl)-phenyl]-phosphonic acid	Investigative	44300226	C25H40N3O6P	509.6	CC[C@@H](C(=O)N(C)CCCC1CCCCC1)NC(=O)[C@H](CC2=CC=C(C=C2)P(=O)(O)O)NC(=O)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1DV8M	1,2,4-Oxadiazole Analogue 14f	Investigative	6326463	C31H29F3N5O7P	671.6	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)CC4=CNC5=CC=CC=C54	IC50 = 62000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1JVP7	(2R,3S,4R,5S)-2-(Hydroxymethyl)-5-(4-methylphenoxy)oxolane-3,4-diol	Investigative	71457659	C12H16O5	240.25	CC1=CC=C(C=C1)O[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O	IC50 = 143400 nM	Poor binder
T85943	Proto-oncogene c-Src	B1K9UL	1-(4-Phenylmethoxyphenyl)-3-piperidin-1-ylpropan-1-one;hydrochloride	Investigative	45260846	C21H26ClNO2	359.9	C1CCN(CC1)CCC(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1KOX8	PD158780 Analog 5k	Investigative	5328357	C20H25BrN6O	445.4	CCN(CC)CC(CNC1=NC=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1MX8Q	(3-Nitro-phenyl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine	Investigative	9860872	C15H11N5O2	293.28	C1=CC(=CC(=C1)[N+](=O)[O-])NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 = 93000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1NZF0	Rac-3-(6-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)quinolin-3-yl)propanamide	Investigative	46232552	C20H17Cl2FN2O2	407.3	CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=CC3=CC(=CN=C3C=C2)CCC(=O)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1P5ZV	[1-(4-Methylpiperazin-1-yl)-3-phenylpropan-2-yl] N-(3-bromophenyl)-N-[6-methylsulfanyl-1-(2-phenylpropyl)pyrazolo[3,4-d]pyrimidin-4-yl]carbamate	Investigative	137636138	C36H40BrN7O2S	714.7	CC(CN1C2=C(C=N1)C(=NC(=N2)SC)N(C3=CC(=CC=C3)Br)C(=O)OC(CC4=CC=CC=C4)CN5CCN(CC5)C)C6=CC=CC=C6	Ki ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1QC6R	N-[[(18S)-3,5-Dioxo-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaen-18-yl]methyl]benzenesulfonamide	Investigative	10650891	C32H28N4O5S	580.7	C1CN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO[C@@H]1CNS(=O)(=O)C6=CC=CC=C6)C7=CC=CC=C75)C(=O)NC4=O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1S9KH	Rac-3-(6-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)quinolin-3-yl)acrylic acid	Investigative	46232554	C20H14Cl2FNO3	406.2	CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=CC3=CC(=CN=C3C=C2)/C=C/C(=O)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1SG2Z	7-(3,5-Dimethyl-1,2-oxazol-4-yl)-N-[4-[2-(1,4-dimethylpiperazin-1-ium-1-yl)ethoxy]phenyl]-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	59837732	C27H34N7O2+	488.6	CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=C(C=C3)OCC[N+]4(CCN(CC4)C)C)C5=C(ON=C5C)C	IC50 = 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	B1VNK3	3-(3,4-Dichlorophenyl)-2-phenyl-6,7-dihydro-5H-indazol-4-one	Investigative	57403803	C19H14Cl2N2O	357.2	C1CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4	IC50 = 65800 nM	Poor binder
T85943	Proto-oncogene c-Src	B2AJI1	4',6-Diamino-5-hydroxyflavone	Investigative	10445729	C15H12N2O3	268.27	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=CC(=C3O)N)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B2FB5Q	N-((5-Bromo-1H-indol-3-yl)(phenyl)methyl)-N-methylbenzenamine	Investigative	54584531	C22H19BrN2	391.3	CN(C1=CC=CC=C1)C(C2=CC=CC=C2)C3=CNC4=C3C=C(C=C4)Br	IC50 = 71600 nM	Poor binder
T85943	Proto-oncogene c-Src	B2KP0J	N-((4-Chlorophenyl)(1H-indol-3-yl)methyl)-N-methylbenzenamine	Investigative	44195626	C22H19ClN2	346.8	CN(C1=CC=CC=C1)C(C2=CC=C(C=C2)Cl)C3=CNC4=CC=CC=C43	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B2NIL7	Di(1,3-dimethyl-1H-2-indolyl) disulfide	Investigative	12484326	C20H20N2S2	352.5	CC1=C(N(C2=CC=CC=C12)C)SSC3=C(C4=CC=CC=C4N3C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B2TL7F	3-(4-Tert-butylphenyl)-2-(3,4-dimethoxyphenyl)-6,6-dimethyl-5,7-dihydroindazol-4-one	Investigative	57398518	C27H32N2O3	432.6	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC=C(C=C3)C(C)(C)C)C4=CC(=C(C=C4)OC)OC)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B2W9YU	3-(2-(4-p-Tolyl-1H-1,2,3-triazol-1-yl)acetyl)-2H-chromen-2-one	Investigative	53325212	C26H19N3O3	421.4	CC1=CC=C(C=C1)C2=CN(N=N2)CC(=O)C3=CC=C(C=C3)C4=CC5=CC=CC=C5OC4=O	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B2X1KJ	1,2,4-Oxadiazole Analogue 5e	Investigative	5329218	C26H27N4O7P	538.5	C[C@@H](C1=NC(=NO1)CC2=CC3=CC=CC=C3C=C2)NC(=O)[C@H](CC4=CC=C(C=C4)OP(=O)(O)O)NC(=O)C	IC50 = 64000 nM	Poor binder
T85943	Proto-oncogene c-Src	B2XAR6	1,2,4-Oxadiazole Analogue 4i	Investigative	5329185	C28H30N5O8P	595.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC(=O)N)C2=NC(=NO2)CC3=CC=CC4=CC=CC=C43	IC50 = 135000 nM	Poor binder
T85943	Proto-oncogene c-Src	B2XPV7	N-{1-[3-(3,4-Dichloro-benzyl)-[1,2,4]oxadiazol-5-yl]-2-hydroxy-ethyl}-3-(4-phosphonooxy-benzyl)-succinamic acid	Investigative	10031003	C22H22Cl2N3O9P	574.3	C1=CC(=CC=C1C[C@H](CC(=O)O)C(=O)N[C@@H](CO)C2=NC(=NO2)CC3=CC(=C(C=C3)Cl)Cl)OP(=O)(O)O	IC50 = 54000 nM	Poor binder
T85943	Proto-oncogene c-Src	B2Y7EI	1,2,4-Oxadiazole Analogue 5m	Investigative	5329196	C22H23ClIN4O7P	648.8	C[C@@H](C1=NC(=NO1)CC2=CC(=C(C=C2)I)Cl)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B2ZJK3	5-Pyridin-4-yl-2-(2,4,6-trichlorophenyl)pyrazol-3-amine	Investigative	56950878	C14H9Cl3N4	339.6	C1=CN=CC=C1C2=NN(C(=C2)N)C3=C(C=C(C=C3Cl)Cl)Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B35LXF	N,alpha-Diphenyl-N,1-dimethyl-1H-indole-3-methaneamine	Investigative	54585467	C23H22N2	326.4	CN1C=C(C2=CC=CC=C21)C(C3=CC=CC=C3)N(C)C4=CC=CC=C4	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B39ESB	Phenyl-(6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-4-yl)-amine	Investigative	13492281	C16H16N4	264.32	C1CCC2=C(C1)C3=C(N2)N=CN=C3NC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3BAW0	(S)-4-[(S)-2-Acetylamino-3-(4-phosphonooxy-phenyl)-propionylamino]-4-[3-(3-methyl-butyl)-[1,2,4]oxadiazol-5-yl]-butyric acid	Investigative	44315809	C22H31N4O9P	526.5	CC(C)CCC1=NOC(=N1)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)OP(=O)(O)O)NC(=O)C	IC50 = 61000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3G0IB	2-(4-Chlorophenyl)-3-cyclohexyl-6,6-dimethyl-[1,3]dioxino[4,5-c]pyrazol-4-one	Investigative	57398517	C19H21ClN2O3	360.8	CC1(OC2=NN(C(=C2C(=O)O1)C3CCCCC3)C4=CC=C(C=C4)Cl)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3GO2V	7-(2,6-Dimethylphenyl)-5-methyl-N-(quinolin-8-yl)benzo[e][1,2,4]triazin-3-amine	Investigative	11560211	C25H21N5	391.5	CC1=C(C(=CC=C1)C)C2=CC3=C(C(=C2)C)N=C(N=N3)NC4=CC=CC5=C4N=CC=C5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3I0GT	(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-3-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-aminohexanoyl]amino]-3-(4-aminophenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	11578809	C44H60N8O10S	893.1	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)N)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)C	IC50 = 93000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3JB9G	5-[(1E)-2-(5,6-Dibromo-2-hydroxy-3-methoxyphenyl)-1-azavinyl]-3-hydrobenzimida zol-2-one	Investigative	4600415	C15H11Br2N3O3	441.07	COC1=CC(=C(C(=C1O)C=NC2=CC3=C(C=C2)NC(=O)N3)Br)Br	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3JBT1	1,2,4-Oxadiazole Analogue 5d	Investigative	5329217	C22H23Cl2N4O7P	557.3	C[C@@H](C1=NC(=NO1)CC2=CC(=C(C=C2)Cl)Cl)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 72000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3JZ8I	(R)-4-{(S)-2-[2-Amino-3-(4-phosphonooxy-phenyl)-propionylamino]-2-carboxy-acetylamino}-5-((S)-1-carboxy-2-methyl-propylcarbamoyl)-pentanoic acid	Investigative	44336731	C23H33N4O13P	604.5	CC(C)[C@@H](C(=O)O)NC(=O)C[C@@H](CCC(=O)O)NC(=O)[C@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)N	IC50 = 83200 nM	Poor binder
T85943	Proto-oncogene c-Src	B3M7WB	4,5-Bis[phenyl(methyl)amino]phthalimide	Investigative	10360971	C22H19N3O2	357.4	CN(C1=CC=CC=C1)C2=C(C=C3C(=C2)C(=O)NC3=O)N(C)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3PL5E	1,2,4-Oxadiazole Analogue 11	Investigative	5329203	C24H26F3N4O7P	570.5	CC[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 98000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3T9QN	Methyl 4-(6-(4-(methoxycarbonylamino)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate	Investigative	44219749	C24H29N7O5	495.5	COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCN(CC4)C(=O)OC)C(=N2)N5CCOCC5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3V7LZ	2-[(Dimethylamino)methyl]-3-(3,4-dimethylphenyl)sulfanyl-1-(4-phenylmethoxyphenyl)propan-1-one;hydrochloride	Investigative	45264671	C27H32ClNO2S	470.1	CC1=C(C=C(C=C1)SCC(CN(C)C)C(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3)C.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B3WG5V	alpha-Sulfophenylacetic acid	Investigative	413605	C8H8O5S	216.21	C1=CC=C(C=C1)C(C(=O)O)S(=O)(=O)O	IC50 = 192000 nM	Poor binder
T85943	Proto-oncogene c-Src	B40NLY	4-Methyl-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	10110378	C23H19N5O	381.4	CC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B43EJH	6-(2-Morpholinoethylamino)-4-(4-phenoxyphenylamino)-1,7-naphthyridine-3-carbonitrile	Investigative	44405504	C27H26N6O2	466.5	C1COCCN1CCNC2=NC=C3C(=C2)C(=C(C=N3)C#N)NC4=CC=C(C=C4)OC5=CC=CC=C5	IC50 = 90000 nM	Poor binder
T85943	Proto-oncogene c-Src	B43WPI	3-[(E)-2-(4-Chlorophenyl)ethenyl]-N-[(2R)-2,3-dihydroxypropyl]-4-methoxybenzamide	Investigative	57325478	C19H20ClNO4	361.8	COC1=C(C=C(C=C1)C(=O)NC[C@H](CO)O)/C=C/C2=CC=C(C=C2)Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B46VDG	N-((1H-Indol-3-yl)(p-tolyl)methyl)-N-methylbenzenamine	Investigative	54586437	C23H22N2	326.4	CC1=CC=C(C=C1)C(C2=CNC3=CC=CC=C32)N(C)C4=CC=CC=C4	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4G2QZ	Methyl 4-(6-(4-aminophenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate	Investigative	44605035	C22H27N7O3	437.5	COC(=O)N1CCC(CC1)N2C3=C(C=N2)C(=NC(=N3)C4=CC=C(C=C4)N)N5CCOCC5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4HX3I	1-Isopropyl-3-(pyrimidin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905171	C12H13N7	255.28	CC(C)N1C2=NC=NC(=C2C(=N1)C3=CN=CN=C3)N	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4JCG9	1,8-Naphthyridin-2(1H)-one deriv. 9p	Investigative	5328730	C22H17Cl2N3O2	426.3	CN1C2=C(C=CC(=N2)NC3=CC=C(C=C3)OC)C=C(C1=O)C4=C(C=CC=C4Cl)Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4K5TJ	4-(3-((4-Hydroxy-3-oxobenzofuran-2(3H)-ylidene)methyl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)-N-(2-hydroxyethyl)benzamide	Investigative	44541014	C26H21N3O5	455.5	CN1C=C(C2=C(C=CN=C21)C3=CC=C(C=C3)C(=O)NCCO)/C=C\\4/C(=O)C5=C(C=CC=C5O4)O	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4LZS2	4-Phenyl-1H-1,2,3-triazole-1-acetic acid methyl ester	Investigative	53318640	C11H11N3O2	217.22	COC(=O)CN1C=C(N=N1)C2=CC=CC=C2	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4MH6G	3N-(3-Pyridyl)-1-methyl-2-[1-methyl-3-(3-pyridylcarbamoyl)-1H-2-indolyldisulfanyl]-1H-3-indolecarboxamide	Investigative	10437879	C30H24N6O2S2	564.7	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)NC5=CN=CC=C5)C(=O)NC6=CN=CC=C6	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4MT5C	1-[2-Amino-6-(2,3,4,5,6-pentamethylphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea	Investigative	5329123	C23H30N6O	406.5	CC1=C(C(=C(C(=C1C)C)C2=C(N=C3C(=C2)C=NC(=N3)N)NC(=O)NC(C)(C)C)C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4NUV6	3,5-Dihydroxy-N-(3-hydroxyphenyl)naphthalene-2-carboxamide	Investigative	21036218	C17H13NO4	295.29	C1=CC2=CC(=C(C=C2C(=C1)O)O)C(=O)NC3=CC(=CC=C3)O	IC50 = 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4OJF2	[4-[2-[(Dimethylamino)methyl]prop-2-enoyl]phenyl] 4-(dimethylcarbamoyl)benzenesulfonate;hydrochloride	Investigative	45260823	C21H25ClN2O5S	453	CN(C)CC(=C)C(=O)C1=CC=C(C=C1)OS(=O)(=O)C2=CC=C(C=C2)C(=O)N(C)C.Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4PWX1	1-Phenylbenzimidazol-4-ol	Investigative	5328458	C13H10N2O	210.23	C1=CC=C(C=C1)N2C=NC3=C2C=CC=C3O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4R7YN	1,2,4-Oxadiazole Analogue 4c	Investigative	5329180	C27H34N5O8P	587.6	CC(C)C1=CC=C(C=C1)CC2=NOC(=N2)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 96000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4TF0B	[4-[[(3R,6S,9R,12S,23S)-6-(2-Amino-2-oxoethyl)-2,5,8,11,14,22-hexaoxo-3,9-di(propan-2-yl)-15-oxa-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44386471	C34H52N7O12P	781.8	CC(C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)NCCCCCOC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)C(C)C)CC(=O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4UNO2	Dithiobis(1H-indole-3-carboxamide) deriv. 10q	Investigative	5328608	C34H30N4O2S2	590.8	CC1=CC2=C(C=C1)C(=C(N2C)SSC3=C(C4=C(N3C)C=C(C=C4)C)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 = 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4VJ6B	{(S)-2-[4-(Benzyloxy-hydroxy-phosphoryloxy)-phenyl]-1-[5-(3-cyclohexyl-propyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylcarbamoyl]-ethyl}-carbamic acid tert-butyl ester	Investigative	44308076	C46H56N3O9PS	858	CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)OCC2=CC=CC=C2)C(=O)NC3C(SC4=CC=CC=C4N(C3=O)CCCC5CCCCC5)C6=CC=C(C=C6)OC	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4WH1Z	1-[2-Amino-6-(2,3,5,6-tetramethylphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea	Investigative	5328125	C22H28N6O	392.5	CC1=CC(=C(C(=C1C)C2=C(N=C3C(=C2)C=NC(=N3)N)NC(=O)NC(C)(C)C)C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B4WJ5T	3-(3,4-Dichlorophenyl)-2-(4-hydroxyphenyl)-6,7-dihydro-5H-indazol-4-one	Investigative	57391515	C19H14Cl2N2O2	373.2	C1CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=C(C=C4)O	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B50FEL	(3-Nitro-phenyl)-(4-pyridin-2-yl-pyrimidin-2-yl)-amine	Investigative	10708835	C15H11N5O2	293.28	C1=CC=NC(=C1)C2=NC(=NC=C2)NC3=CC(=CC=C3)[N+](=O)[O-]	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B51KGD	[5-Amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(6-phenyl-1H-indol-2-yl)methanone	Investigative	68005486	C26H20N6O	432.5	CC1=NC2=C(N1)C=C(C=C2)N3C(=C(C=N3)C(=O)C4=CC5=C(N4)C=C(C=C5)C6=CC=CC=C6)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B53ECV	N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	9864718	C23H19N5O	381.4	CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B56RNZ	2-(3-Chlorophenyl)-3-(3,4-dichlorophenyl)-6,6-dimethyl-5,7-dihydroindazol-4-one	Investigative	57396827	C21H17Cl3N2O	419.7	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC(=CC=C4)Cl)C	IC50 = 50700 nM	Poor binder
T85943	Proto-oncogene c-Src	B57RGK	7-Mesityl-5-methyl-N-phenylbenzo[e][1,2,4]triazin-3-amine	Investigative	18455722	C23H22N4	354.4	CC1=CC(=C(C(=C1)C)C2=CC3=C(C(=C2)C)N=C(N=N3)NC4=CC=CC=C4)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B58QTS	Ca-YEEIE	Investigative	44324728	C39H49N5O16	843.8	CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)/C=C/C2=CC(=C(C=C2)O)O	IC50 = 54000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5A0FP	1,2,4-Oxadiazole Analogue 5a	Investigative	6326454	C23H27N4O7P	502.5	CC1=CC=C(C=C1)CC2=NOC(=N2)[C@H](C)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 65000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5F1NP	5-Substituted 1-Phenylbenzimidazole 19	Investigative	5328509	C19H21N3O2	323.4	C1COCCN1CCOC2=CC3=C(C=C2)N(C=N3)C4=CC=CC=C4	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5FW8N	2-(4-(4-Fluoro-3-methylphenyl)-1H-1,2,3-triazol-1-yl)-1-phenylethanone	Investigative	53319964	C17H14FN3O	295.31	CC1=C(C=CC(=C1)C2=CN(N=N2)CC(=O)C3=CC=CC=C3)F	IC50 = 81000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5G7ID	5-(Oxiran-2-ylmethoxy)-1-phenylbenzimidazole	Investigative	5328503	C16H14N2O2	266.29	C1C(O1)COC2=CC3=C(C=C2)N(C=N3)C4=CC=CC=C4	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5KD4L	(2S)-1-(1H-Indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxy-propan-2-amine	Investigative	6914611	C25H22N4O	394.5	C1=CC=C2C(=C1)C(=CN2)C[C@@H](COC3=CN=CC(=C3)C4=CC5=C(C=C4)C=NC=C5)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5MT1H	1-(2-Oxopropyl)-4-phenyl-1H-1,2,3-triazole	Investigative	53323927	C11H11N3O	201.22	CC(=O)CN1C=C(N=N1)C2=CC=CC=C2	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5NH8A	Rac-3-(6-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)quinolin-3-yl)-N-methylacrylamide	Investigative	46232512	C21H17Cl2FN2O2	419.3	CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=CC3=CC(=CN=C3C=C2)/C=C/C(=O)NC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5ON0T	6-(1,9-Diazaspiro[5.5]undecan-9-Yl)-9h-Purine	Investigative	70789254	C14H20N6	272.35	C1CCNC2(C1)CCN(CC2)C3=NC=NC4=C3NC=N4	IC50 = 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5PT4J	(2R,3S,4R,5S)-2-(Hydroxymethyl)-5-(3-methoxyphenoxy)oxolane-3,4-diol	Investigative	71457660	C12H16O6	256.25	COC1=CC(=CC=C1)O[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O	IC50 = 95000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5QWD7	3-(3,4-Dichlorophenyl)-2-(3-hydroxy-4-methoxyphenyl)-6,7-dihydro-5H-indazol-4-one	Investigative	57400187	C20H16Cl2N2O3	403.3	COC1=C(C=C(C=C1)N2C(=C3C(=N2)CCCC3=O)C4=CC(=C(C=C4)Cl)Cl)O	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5RL4N	2-[(Dimethylamino)methyl]-1-(4-phenylmethoxyphenyl)prop-2-en-1-one;hydrochloride	Investigative	45260877	C19H22ClNO2	331.8	CN(C)CC(=C)C(=O)C1=CC=C(C=C1)OCC2=CC=CC=C2.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5T2OH	Ca-DOPA-EEIE	Investigative	44324769	C39H49N5O17	859.8	CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC(=C(C=C1)O)O)NC(=O)/C=C/C2=CC(=C(C=C2)O)O	IC50 = 55000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5T4JC	4-(4-Methoxyanilino)-5-anilinophthalimide	Investigative	10043994	C21H17N3O3	359.4	COC1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=CC=C4	IC50 = 64000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5TMG6	1-Phenylbenzimidazole-5,6-diol	Investigative	5328526	C13H10N2O2	226.23	C1=CC=C(C=C1)N2C=NC3=CC(=C(C=C32)O)O	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5WB7E	[[2-[(Dimethylamino)methyl]-3-oxo-3-(4-phenylmethoxyphenyl)propyl]amino]urea;hydrochloride	Investigative	45264655	C20H27ClN4O3	406.9	CN(C)CC(CNNC(=O)N)C(=O)C1=CC=C(C=C1)OCC2=CC=CC=C2.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5WJ8A	((S)-2-[4-(Benzyloxy-hydroxy-phosphoryloxy)-phenyl]-1-{2-(4-methoxy-phenyl)-5-[(2-methoxy-phenylcarbamoyl)-methyl]-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylcarbamoyl}-ethyl)-carbamic acid tert-butyl ester	Investigative	44307989	C46H49N4O11PS	896.9	CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)OCC2=CC=CC=C2)C(=O)NC3C(SC4=CC=CC=C4N(C3=O)CC(=O)NC5=CC=CC=C5OC)C6=CC=C(C=C6)OC	IC50 = 95000 nM	Poor binder
T85943	Proto-oncogene c-Src	B5Y9AP	6-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]quinoline	Investigative	46232510	C17H12Cl2FNO	336.2	CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=CC3=C(C=C2)N=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B62HFX	3-(3-Chloro-4-methylphenyl)-2-(3-methoxyphenyl)-6,7-dihydro-5H-indazol-4-one	Investigative	57391516	C21H19ClN2O2	366.8	CC1=C(C=C(C=C1)C2=C3C(=NN2C4=CC(=CC=C4)OC)CCCC3=O)Cl	IC50 = 82700 nM	Poor binder
T85943	Proto-oncogene c-Src	B62LBZ	1,2,4-Oxadiazole Analogue 5g	Investigative	5329189	C23H24F3N4O7P	556.4	C[C@@H](C1=NC(=NO1)CC2=CC(=CC=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 115000 nM	Poor binder
T85943	Proto-oncogene c-Src	B63KDX	N-((4-Chlorophenyl)(1-methyl-1H-indol-3-yl)methyl)-N-methylbenzenamine	Investigative	53358308	C23H21ClN2	360.9	CN1C=C(C2=CC=CC=C21)C(C3=CC=C(C=C3)Cl)N(C)C4=CC=CC=C4	IC50 = 98300 nM	Poor binder
T85943	Proto-oncogene c-Src	B64LEZ	2-(4-((4-Amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-1-phenylethanone	Investigative	53322859	C22H18N8O	410.4	C1=CC=C(C=C1)C2=NN(C3=NC=NC(=C23)N)CC4=CN(N=N4)CC(=O)C5=CC=CC=C5	IC50 ~ 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	B65HCJ	4-[4-(2-Dimethylaminomethyl-acryloyl)-phenoxysulfonyl]-benzoic acid	Investigative	10318154	C19H19NO6S	389.4	CN(C)CC(=C)C(=O)C1=CC=C(C=C1)OS(=O)(=O)C2=CC=C(C=C2)C(=O)O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B65JHE	1-[7-Amino-3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-yl]-3-ethylurea	Investigative	5328998	C19H21N5O3	367.4	CCNC(=O)NC1=C(C=C2C=NC(=CC2=N1)N)C3=CC(=CC(=C3)OC)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B65ZRF	5-Substituted 1-Phenylbenzimidazole 26	Investigative	5328516	C16H15N3OS	297.4	CN(C)C(=S)OC1=CC2=C(C=C1)N(C=N2)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6B0VS	(3Ar)-13,13,16-Trimethyl-15-Oxo-1,2,3,3a,4,5,12,14,15,17,18,19-Dodecahydro-13h-10,6-(Metheno)pyrrolo[2',1':3,4][1,4,9]triazacyclotetradecino[9,8-A]indole-7-Carboxamide	Investigative	53326941	C26H34N4O2	434.6	CC1=C2CCCN3CCC[C@@H]3CNC4=C(C=CC(=C4)N2C5=C1C(=O)CC(C5)(C)C)C(=O)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6DAL3	Dithiobis(1H-indole-3-carboxamide) deriv. 10c	Investigative	5328594	C34H30N4O2S2	590.8	CC1=C2C(=CC=C1)N(C(=C2C(=O)NC3=CC=CC=C3)SSC4=C(C5=C(C=CC=C5N4C)C)C(=O)NC6=CC=CC=C6)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6ERQ3	1-Isopropyl-3-(2-methylquinolin-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905208	C18H18N6	318.4	CC1=NC2=C(C=C1)C=C(C=C2)C3=NN(C4=NC=NC(=C34)N)C(C)C	IC50 = 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6I1PT	N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-acetamide	Investigative	44273620	C18H17N5O	319.4	CC1=C(C=C(C=C1)NC(=O)C)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6J9NQ	4-Pyridin-4-yl-N-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]pyrimidin-2-amine	Investigative	9799152	C17H12F4N4O	364.3	C1=CC(=CC(=C1)OC(C(F)F)(F)F)NC2=NC=CC(=N2)C3=CC=NC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6JFQ9	(2S,3S)-2-((S)-2-{(S)-2-[(S)-2-Amino-3-(4-hydroxy-phenyl)-1-oxo-propylamino]-4-carboxy-1-oxo-butylamino}-4-carboxy-1-oxo-butylamino)-3-methyl-pentanoic acid	Investigative	16741056	C25H36N4O10	552.6	CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6NB9U	2-(4-Chlorophenyl)-3-(3,4-dichlorophenyl)-6,6-dimethyl-5,7-dihydroindazol-4-one	Investigative	56930741	C21H17Cl3N2O	419.7	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)C	IC50 = 86000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6PQX3	2-Thioxo-1H-indole-3-carboxamide deriv. 13	Investigative	5328623	C22H18N2OS2	390.5	CN1C2=CC=CC=C2C(=C1SSC3=CC=CC=C3)C(=O)NC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6PZ0U	N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]naphthalene-2-carboxamide	Investigative	10181160	C27H21N5O	431.5	CC1=C(C=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C=C2)NC4=NC=CC(=N4)C5=CN=CC=C5	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6Q0PD	Wee1 Inhibitor	Investigative	10384072	C20H11ClN2O3	362.8	C1=CC=C(C(=C1)C2=CC3=C(C4=C(N3)C=CC(=C4)O)C5=C2C(=O)NC5=O)Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6Q5JF	(2S)-2-[[(2S)-2-[[(3S,6S,9R,20S)-6-[(2S)-Butan-2-yl]-3-[(4-hydroxyphenyl)methyl]-2,5,8,11,14-pentaoxo-9-(sulfanylmethyl)-1,4,7,10,15-pentazacycloicosane-20-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	11571561	C46H59N7O12S	934.1	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCNC(=O)CCC(=O)N[C@H](C(=O)N1)CS)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)CC4=CC=C(C=C4)O	IC50 = 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6R9FG	Dithiobis(1H-indole-3-carboxamide) deriv. 10d	Investigative	5328595	C34H30N4O4S2	622.8	CN1C2=C(C(=CC=C2)OC)C(=C1SSC3=C(C4=C(N3C)C=CC=C4OC)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6RE9N	4-[[4-[2-Methylene-3-(dimethylamino)propionyl]phenoxy]sulfonyl]salicylic acid	Investigative	10408993	C19H19NO7S	405.4	CN(C)CC(=C)C(=O)C1=CC=C(C=C1)OS(=O)(=O)C2=CC(=C(C=C2)C(=O)O)O	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6RHC4	1,2,4-Oxadiazole Analogue 14c	Investigative	6326461	C29H26F5N4O7P	668.5	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)CC4=CC(=C(C=C4)F)F	IC50 = 130000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6S1XC	3-(3,4-Dichlorophenyl)-6,6-dimethyl-2-(4-nitrophenyl)-5,7-dihydroindazol-4-one	Investigative	57393341	C21H17Cl2N3O3	430.3	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=C(C=C4)[N+](=O)[O-])C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6UF4W	Ethyl 5-amino-3-pyridin-4-yl-1-(2,4,6-trichlorophenyl)pyrazole-4-carboxylate	Investigative	56950741	C17H13Cl3N4O2	411.7	CCOC(=O)C1=C(N(N=C1C2=CC=NC=C2)C3=C(C=C(C=C3Cl)Cl)Cl)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6VNI1	8-(4-Hydroxyanilino)-1-(3-morpholin-4-ylpropyl)-[1,3]oxazolo[4,5-g]quinazolin-2-one	Investigative	70694945	C22H23N5O4	421.4	C1COCCN1CCCN2C3=C(C=C4C(=C3)C(=NC=N4)NC5=CC=C(C=C5)O)OC2=O	IC50 = 66000 nM	Poor binder
T85943	Proto-oncogene c-Src	B6XD1U	1,2,4-Oxadiazole Analogue 4k	Investigative	5329186	C25H30N5O8P	559.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC(=O)N)C2=NC(=NO2)CCC3=CC=CC=C3	IC50 = 156000 nM	Poor binder
T85943	Proto-oncogene c-Src	B78MUR	5-[(1E)-2-(5,6-Dibromo-3-ethoxy-2-hydroxyphenyl)-1-azavinyl]-3-hydrobenzimidaz ol-2-one	Investigative	1128774	C16H13Br2N3O3	455.1	CCOC1=CC(=C(C(=C1O)C=NC2=CC3=C(C=C2)NC(=O)N3)Br)Br	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B79JYK	2-(4-p-Tolyl-1H-1,2,3-triazol-1-yl)cycloheptanone	Investigative	53321272	C16H19N3O	269.34	CC1=CC=C(C=C1)C2=CN(N=N2)C3CCCCCC3=O	IC50 = 66100 nM	Poor binder
T85943	Proto-oncogene c-Src	B79PYV	(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(3-fluoro-phenyl)-amine	Investigative	10729749	C14H13FN4	256.279	CC1=C(NC2=C1C(=NC=N2)NC3=CC(=CC=C3)F)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7BZJ1	2-Cyano-2-(3,4-dihydroxy-benzyl)-thioacetamide	Investigative	44318047	C10H10N2O2S	222.27	C1=CC(=C(C=C1CC(C#N)C(=S)N)O)O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7C8SX	[4-[[(3R,6S,9R,12S,23S)-6-(2-Amino-2-oxoethyl)-2,5,8,11,14,22-hexaoxo-3,9-di(propan-2-yl)-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44386888	C35H54N7O11P	779.8	CC(C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)NCCCCCCC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)C(C)C)CC(=O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7DI2G	1-Phenyl-5-propoxybenzimidazole	Investigative	5328498	C16H16N2O	252.31	CCCOC1=CC2=C(C=C1)N(C=N2)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7HC8A	Methyl 2-oxo-2-[[3-[5-(3-phenoxyprop-1-ynyl)thiophen-3-yl]-1,4-dihydroindeno[1,2-c]pyrazol-5-yl]amino]acetate	Investigative	44440259	C26H19N3O4S	469.5	COC(=O)C(=O)NC1=CC=CC2=C1CC3=C2NN=C3C4=CSC(=C4)C#CCOC5=CC=CC=C5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7IFH6	[5-[[(1S)-1-[3-[(3,4-Dichlorophenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]carbamoylamino]naphthalen-2-yl] dihydrogen phosphate	Investigative	44332978	C22H19Cl2N4O6P	537.3	C[C@@H](C1=NC(=NO1)CC2=CC(=C(C=C2)Cl)Cl)NC(=O)NC3=CC=CC4=C3C=CC(=C4)OP(=O)(O)O	IC50 = 198000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7M1FV	4',6,8-Triamino-7-hydroxyflavone	Investigative	10356450	C15H13N3O3	283.28	C1=CC(=CC=C1C2=CC(=O)C3=CC(=C(C(=C3O2)N)O)N)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7MHU4	2-(1-Phenylbenzimidazol-5-yl)oxyethanamine	Investigative	5328505	C15H15N3O	253.3	C1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)OCCN	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7MS9I	(2S,3R)-2-[[(4S)-4-[[(2S)-2-[[(2S)-2-Amino-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoic acid	Investigative	56671742	C25H37N4O13P	632.6	CC[C@@H](C)[C@@H](C(=O)O)NC(=O)CC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7N1WR	3-[(E)-2-(4-Chlorophenyl)ethenyl]-N-[(2S)-2,3-dihydroxypropyl]-4-methoxybenzamide	Investigative	57325479	C19H20ClNO4	361.8	COC1=C(C=C(C=C1)C(=O)NC[C@@H](CO)O)/C=C/C2=CC=C(C=C2)Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7O6XG	2-(4-(4-Fluoro-3-methylphenyl)-1H-1,2,3-triazol-1-yl)-1-p-tolylethanone	Investigative	25268881	C18H16FN3O	309.3	CC1=CC=C(C=C1)C(=O)CN2C=C(N=N2)C3=CC(=C(C=C3)F)C	IC50 = 82300 nM	Poor binder
T85943	Proto-oncogene c-Src	B7P4ZG	1-[2-(Furan-2-yl)pyrrolidin-1-yl]prop-2-en-1-one	Investigative	51346068	C11H13NO2	191.23	C=CC(=O)N1CCCC1C2=CC=CO2	Ki = 160000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7PGN4	(2S,3R)-2-[[(2S)-2-[[(3S)-3-[[(2S)-2-Acetamido-3-(4-phosphonooxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoic acid	Investigative	56664866	C26H37N4O14P	660.6	CC[C@@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C	IC50 = 75400 nM	Poor binder
T85943	Proto-oncogene c-Src	B7S5TZ	1-(2-(4-Decyl-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	53322857	C25H34N8	446.6	CCCCCCCCCCC1=CN(N=N1)CCN2C3=NC=NC(=C3C(=N2)C4=CC=CC=C4)N	IC50 ~ 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	B7WIF2	N-Methyl-N-((1-methyl-1H-indol-3-yl)(p-tolyl)methyl)benzenamine	Investigative	53358309	C24H24N2	340.5	CC1=CC=C(C=C1)C(C2=CN(C3=CC=CC=C32)C)N(C)C4=CC=CC=C4	IC50 = 60500 nM	Poor binder
T85943	Proto-oncogene c-Src	B7Z2YV	Di(3-phenyl-1H-2-indolyl) disulfide	Investigative	15249955	C28H20N2S2	448.6	C1=CC=C(C=C1)C2=C(NC3=CC=CC=C32)SSC4=C(C5=CC=CC=C5N4)C6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B85KAN	1,2,4-Oxadiazole Analogue 15a	Investigative	5329226	C29H28F3N4O8P	648.5	C1=CC=C(C=C1)CC(=O)N[C@@H](CC2=CC=C(C=C2)OP(=O)(O)O)C(=O)N[C@@H](CO)C3=NC(=NO3)CC4=CC=C(C=C4)C(F)(F)F	IC50 = 161000 nM	Poor binder
T85943	Proto-oncogene c-Src	B86AKW	[4-[[(3S,6R,9S,12R,15S,22R)-15-Acetamido-6-(2-amino-2-oxoethyl)-9-(cyclohexylmethyl)-2,5,8,11,14,21-hexaoxo-3-propan-2-yl-1,4,7,10,13,20-hexazabicyclo[20.3.0]pentacosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44386410	C40H61N8O12P	876.9	CC(C)[C@H]1C(=O)N2CCC[C@@H]2C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC(=O)N)CC3CCCCC3)CC4=CC=C(C=C4)OP(=O)(O)O)NC(=O)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8AS5O	1,2,4-Oxadiazole Analogue 14a	Investigative	6326460	C29H28F3N4O7P	632.5	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)CC4=CC=CC=C4	IC50 = 123000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8BQ0O	1,4-Diphenyl-1,2,3,4-tetrahydro-pyrrolo[3,4-g]quinoxaline-6,8-dione	Investigative	10450849	C22H17N3O2	355.4	C1CN(C2=C(N1C3=CC=CC=C3)C=C4C(=C2)C(=O)NC4=O)C5=CC=CC=C5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8DPH0	N-((1H-Indol-3-yl)(4-hydroxy phenyl)methyl)-N-methylbenzenamine	Investigative	54582579	C22H20N2O	328.4	CN(C1=CC=CC=C1)C(C2=CC=C(C=C2)O)C3=CNC4=CC=CC=C43	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8DZ0Y	[4-[(2S)-2-Acetamido-3-oxo-3-[[(1S)-1-(3-pentyl-1,2,4-oxadiazol-5-yl)propyl]amino]propyl]phenyl] dihydrogen phosphate	Investigative	44315968	C21H31N4O7P	482.5	CCCCCC1=NOC(=N1)[C@H](CC)NC(=O)[C@H](CC2=CC=C(C=C2)OP(=O)(O)O)NC(=O)C	IC50 = 65000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8FA3E	2-Propen-1-one, 2-((dimethylamino)methyl)-1-phenyl-, hydrochloride	Investigative	3063374	C12H16ClNO	225.71	CN(C)CC(=C)C(=O)C1=CC=CC=C1.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8ICP3	N-(4-Butylphenyl)-7-(3,5-dimethoxyphenyl)-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	59837640	C26H28N4O2	428.5	CCCCC1=CC=C(C=C1)NC2=NC3=C(C=C(C=C3C)C4=CC(=CC(=C4)OC)OC)N=N2	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8IJH7	3-[8-(Aminomethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione	Investigative	2404	C26H24N4O2	424.5	CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C5CC(CCN5C6=CC=CC=C64)CN	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8ILP6	3-(3,4-Dichlorophenyl)-6,6-dimethyl-2-phenyl-5,7-dihydroindazol-4-one	Investigative	57402052	C21H18Cl2N2O	385.3	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4)C	IC50 = 62100 nM	Poor binder
T85943	Proto-oncogene c-Src	B8KL3X	Methyl 3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoate	Investigative	11438191	C17H14N4O2	306.32	COC(=O)C1=CC(=CC=C1)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 = 90000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8L4ZB	3-Cyclohexyl-2-(4-methylphenyl)-6,7-dihydro-5H-indazol-4-one	Investigative	57394999	C20H24N2O	308.4	CC1=CC=C(C=C1)N2C(=C3C(=N2)CCCC3=O)C4CCCCC4	IC50 = 57700 nM	Poor binder
T85943	Proto-oncogene c-Src	B8LH0Z	(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-naphthalen-1-yloxyoxolane-3,4-diol	Investigative	69912574	C15H16O5	276.28	C1=CC=C2C(=C1)C=CC=C2O[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	IC50 = 184700 nM	Poor binder
T85943	Proto-oncogene c-Src	B8N7ZQ	7-(3,5-Dimethoxyphenyl)-N-(4-ethoxyphenyl)-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	59837598	C24H24N4O3	416.5	CCOC1=CC=C(C=C1)NC2=NC3=C(C=C(C=C3C)C4=CC(=CC(=C4)OC)OC)N=N2	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8Q7IB	2-Methoxy-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	10157645	C23H19N5O2	397.4	COC1=CC=CC=C1C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8T0XB	N-((1H-Indol-3-yl)(3-nitrophenyl)methyl)-N-methylbenzenamine	Investigative	53358307	C22H19N3O2	357.4	CN(C1=CC=CC=C1)C(C2=CC(=CC=C2)[N+](=O)[O-])C3=CNC4=CC=CC=C43	IC50 = 58300 nM	Poor binder
T85943	Proto-oncogene c-Src	B8VMT5	[5-Amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(6-bromo-1H-indol-2-yl)methanone	Investigative	66556938	C20H15BrN6O	435.3	CC1=NC2=C(N1)C=C(C=C2)N3C(=C(C=N3)C(=O)C4=CC5=C(N4)C=C(C=C5)Br)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8WJ6T	Dithiobis(1H-indole-3-carboxamide) deriv. 10i	Investigative	5328600	C34H30N4O2S2	590.8	CC1=CC2=C(C=C1)N(C(=C2C(=O)NC3=CC=CC=C3)SSC4=C(C5=C(N4C)C=CC(=C5)C)C(=O)NC6=CC=CC=C6)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8XG9W	3-{[(1R)-1-Phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione	Investigative	15295578	C17H15N3O2	293.32	C[C@H](C1=CC=CC=C1)NC2=C(C(=O)C2=O)NC3=CC=NC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8XZR4	5-Substituted 1-Phenylbenzimidazole 32	Investigative	5328522	C16H13BrN2O	329.19	C=CCOC1=C(C2=C(C=C1)N(C=N2)C3=CC=CC=C3)Br	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8YOV5	6-Methoxy-3-phenylbenzimidazole-5-carboxylic acid	Investigative	5328530	C15H12N2O3	268.27	COC1=CC2=C(C=C1C(=O)O)N(C=N2)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8YTQ3	CID 49806721	Investigative	49806721	C28H30N4O2	454.6	CCC1=CC2=C(C=C1N3CCN(CC3)C4COC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B8ZFX6	1,8-Naphthyridin-2(1H)-one deriv. 9a	Investigative	5328726	C15H11Cl2N3O	320.2	CN1C2=C(C=CC(=N2)N)C=C(C1=O)C3=C(C=CC=C3Cl)Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B96NEQ	7-(3,5-Dimethoxyphenyl)-N-(3,4-dimethylphenyl)-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	59837599	C24H24N4O2	400.5	CC1=C(C=C(C=C1)NC2=NC3=C(C=C(C=C3C)C4=CC(=CC(=C4)OC)OC)N=N2)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B97JXE	3-(3-Chloro-4-methylphenyl)-6,6-dimethyl-2-pyridin-4-yl-5,7-dihydroindazol-4-one	Investigative	57396744	C21H20ClN3O	365.9	CC1=C(C=C(C=C1)C2=C3C(=NN2C4=CC=NC=C4)CC(CC3=O)(C)C)Cl	IC50 = 74300 nM	Poor binder
T85943	Proto-oncogene c-Src	B9CU5F	7-Hydroxy-2-[[7-hydroxy-1-methyl-3-(phenylcarbamoyl)indol-2-yl]disulfanyl]-1-methyl-N-phenylindole-3-carboxamide	Investigative	5328616	C32H26N4O4S2	594.7	CN1C2=C(C=CC=C2O)C(=C1SSC3=C(C4=C(N3C)C(=CC=C4)O)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9D4MT	[4-[[(3S,6R,9S,12R,15S,22R)-6-(2-Amino-2-oxoethyl)-15-(ethanethioylamino)-2,5,8,11,14,21-hexaoxo-3,9-di(propan-2-yl)-1,4,7,10,13,20-hexazabicyclo[20.3.0]pentacosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44385763	C36H55N8O11PS	838.9	CC(C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)NC(=S)C)C(C)C)CC(=O)N	IC50 = 55000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9DEP0	1-Methyl-2-[[1-methyl-3-(thiophen-2-ylcarbamoyl)indol-2-yl]disulfanyl]-N-thiophen-2-ylindole-3-carboxamide	Investigative	10076837	C28H22N4O2S4	574.8	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)NC5=CC=CS5)C(=O)NC6=CC=CS6	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9JZ6L	Cot inhibitor-2	Investigative	44143370	C26H25Cl2FN8	539.4	CCN1CCC(CC1)N2C=C(N=N2)CNC3=CC4=C(C(=CN=C4C(=C3)Cl)C#N)NC5=CC(=C(C=C5)F)Cl	IC50 = 53000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9MJT0	(S)-4-[(S)-2-Acetylamino-3-(4-phosphonooxy-phenyl)-propionylamino]-4-(3-benzyl-[1,2,4]oxadiazol-5-yl)-butyric acid	Investigative	44315883	C24H27N4O9P	546.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC(=O)O)C2=NC(=NO2)CC3=CC=CC=C3	IC50 = 92000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9MO5H	N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine	Investigative	9965429	C16H15N5	277.32	CC1=C(C=C(C=C1)N)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9O7VY	5-Substituted 1-Phenylbenzimidazole 20	Investigative	5328510	C20H23N3O2	337.4	C1COCCN1CCCOC2=CC3=C(C=C2)N(C=N3)C4=CC=CC=C4	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9OES1	1-(3-(8-(Pyridin-4-ylmethylamino)imidazo[1,2-a]pyrazin-6-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea	Investigative	11755812	C26H20F3N7O	503.5	C1=CC(=CC(=C1)NC(=O)NC2=CC=CC(=C2)C(F)(F)F)C3=CN4C=CN=C4C(=N3)NCC5=CC=NC=C5	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9QJ1U	N-Ethyl-2-(4-phenyl-1H-1,2,3-triazol-1-yl)acetamide	Investigative	53317360	C12H14N4O	230.27	CCNC(=O)CN1C=C(N=N1)C2=CC=CC=C2	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9UZJ6	5-Substituted 1-Phenylbenzimidazole 11	Investigative	5328501	C16H14N2O	250.29	C=CCOC1=CC2=C(C=C1)N(C=N2)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9VIC5	[2-[[(1S)-1-[3-[(3,4-Dichlorophenyl)methyl]-1,2,4-oxadiazol-5-yl]ethyl]carbamoyl]-1H-indol-5-yl] dihydrogen phosphate	Investigative	100942265	C20H17Cl2N4O6P	511.2	C[C@@H](C1=NC(=NO1)CC2=CC(=C(C=C2)Cl)Cl)NC(=O)C3=CC4=C(N3)C=CC(=C4)OP(=O)(O)O	IC50 = 81000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9WC3V	2-Thioxo-1H-indole-3-carboxamide deriv. 11	Investigative	5328621	C17H16N2OS	296.4	CC1(C2=CC=CC=C2N(C1=S)C)C(=O)NC3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	B9ZB2K	4,5-Bis[4-(diethylamino)anilino]phthalimide	Investigative	10434923	C28H33N5O2	471.6	CCN(CC)C1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)N(CC)CC	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BA3C2F	1-(2-(4-Butyl-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	53318898	C19H22N8	362.4	CCCCC1=CN(N=N1)CCN2C3=NC=NC(=C3C(=N2)C4=CC=CC=C4)N	IC50 ~ 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BA3GT5	[4-[[(3S,6R,9S,12R,15S,22R)-15-Acetamido-6-(2-amino-2-oxoethyl)-3-(cyclohexylmethyl)-2,5,8,11,14,21-hexaoxo-9-propan-2-yl-1,4,7,10,13,20-hexazabicyclo[20.3.0]pentacosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44385517	C40H61N8O12P	876.9	CC(C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C)CC4CCCCC4)CC(=O)N	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BA3M0Y	1,2,4-Oxadiazole Analogue 14b	Investigative	5329209	C27H26F3N4O7PS	638.6	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)CC4=CC=CS4	IC50 = 143000 nM	Poor binder
T85943	Proto-oncogene c-Src	BA62KJ	N-(3-Bromophenyl)-1H-imidazo[4,5-g]quinazolin-8-amine	Investigative	2428	C15H10BrN5	340.18	C1=CC(=CC(=C1)Br)NC2=NC=NC3=CC4=C(C=C32)NC=N4	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BA6TG4	(E)-N-(4-Methyl-3-(2-(6-(cyclopropylamino)-9H-purin-9-yl)vinyl)-phenyl)-3-(trifluoromethyl)benzamide	Investigative	44221514	C25H21F3N6O	478.5	CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)/C=C/N3C=NC4=C(N=CN=C43)NC5CC5	IC50 = 91000 nM	Poor binder
T85943	Proto-oncogene c-Src	BAR27X	3-(4-Phosphonooxy-benzyl)-N-{1-[3-(4-trifluoromethyl-benzyl)-[1,2,4]oxadiazol-5-yl]-ethyl}-succinamic acid	Investigative	9985193	C23H23F3N3O8P	557.4	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)CC(=O)O	IC50 = 102000 nM	Poor binder
T85943	Proto-oncogene c-Src	BB4D1Z	N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine	Investigative	10686149	C16H13N5O2	307.31	CC1=C(C=C(C=C1)[N+](=O)[O-])NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BB6FV5	7-Phenylbenzo[e][1,2,4]triazin-3-amine	Investigative	44419371	C13H10N4	222.24	C1=CC=C(C=C1)C2=CC3=C(C=C2)N=C(N=N3)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BB6X8E	7-(3,5-Dimethoxyphenyl)-N-(2,4-dimethylphenyl)-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	59837611	C24H24N4O2	400.5	CC1=CC(=C(C=C1)NC2=NC3=C(C=C(C=C3C)C4=CC(=CC(=C4)OC)OC)N=N2)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BB72VM	1,2,4-Oxadiazole Analogue 13c	Investigative	5329225	C29H29Cl2N4O7P	647.4	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC2=CC=CC=C2)C3=NC(=NO3)CC4=CC(=C(C=C4)Cl)Cl	IC50 = 60000 nM	Poor binder
T85943	Proto-oncogene c-Src	BB80MQ	2-[(Dimethylamino)methyl]-1-(4-phenylmethoxyphenyl)-3-phenylsulfanylpropan-1-one;hydrochloride	Investigative	45264640	C25H28ClNO2S	442	CN(C)CC(CSC1=CC=CC=C1)C(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3.Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BBA30D	4-Phenyl-1-(4-phenyl-1H-1,2,3-triazol-1-yl)but-3-en-2-one	Investigative	53318638	C18H15N3O	289.3	C1=CC=C(C=C1)/C=C/C(=O)CN2C=C(N=N2)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BBC79Y	3-(1H-Indol-3-yl)-4-[1-(1-methyl-piperidin-4-yl)-1H-indol-3-yl]-pyrrole-2,5-dione	Investigative	11729563	C26H24N4O2	424.5	CN1CCC(CC1)N2C=C(C3=CC=CC=C32)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65	IC50 = 83000 nM	Poor binder
T85943	Proto-oncogene c-Src	BBD4X5	2-(Morpholin-4-ylmethyl)-1-(4-phenylmethoxyphenyl)prop-2-en-1-one;hydrochloride	Investigative	45260829	C21H24ClNO3	373.9	C=C(CN1CCOCC1)C(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BBE5Z0	6-{5-[(2S)-2-Amino-3-(1H-indol-3-yl)propoxy]-2-ethynylpyridin-3-yl}isoquinoline	Investigative	23647573	C27H22N4O	418.5	C#CC1=C(C=C(C=N1)OC[C@H](CC2=CNC3=CC=CC=C32)N)C4=CC5=C(C=C4)C=NC=C5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BBH65Q	4,5-Bis(cyclohexylamino)phthalimide	Investigative	10450005	C20H27N3O2	341.4	C1CCC(CC1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4CCCCC4	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BBPQ16	4,5-Dimethoxy-1-phenylbenzimidazole	Investigative	5328520	C15H14N2O2	254.28	COC1=C(C2=C(C=C1)N(C=N2)C3=CC=CC=C3)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BBRN86	(2S,3R)-2-[[(3S)-3-[[(2S)-2-[[(2S)-2-Amino-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-carboxypropanoyl]amino]-3-methylpentanoic acid	Investigative	56681756	C24H35N4O13P	618.5	CC[C@@H](C)[C@@H](C(=O)O)NC(=O)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BBWU45	6-(4-Amino-1-cyclopentyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)quinolin-2(1H)-one	Investigative	24905227	C19H18N6O	346.4	C1CCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC5=C(C=C4)NC(=O)C=C5)N	IC50 = 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BC8XV0	[4-(4-Chloro-phenyl)-pyrimidin-2-yl]-[3-(1,1,2,2-tetrafluoro-ethoxy)-phenyl]-amine	Investigative	19966997	C18H12ClF4N3O	397.8	C1=CC(=CC(=C1)OC(C(F)F)(F)F)NC2=NC=CC(=N2)C3=CC=C(C=C3)Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BCD45N	1-(4-Chlorophenyl)-2-(4-(thiophen-3-yl)-1H-1,2,3-triazol-1-yl)ethanone	Investigative	53317356	C20H14ClN3OS	379.9	C1=CC(=CC(=C1)C2=CN(N=N2)CC(=O)C3=CC=C(C=C3)Cl)C4=CSC=C4	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BCVT06	2-Thioxo-1H-indole-3-carboxamide deriv. 14	Investigative	5328624	C23H20N2OS2	404.6	CN1C2=CC=CC=C2C(=C1SSCC3=CC=CC=C3)C(=O)NC4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BCXK97	2-[(Dimethylamino)methyl]-1-(3-hydroxy-4-phenylmethoxyphenyl)prop-2-en-1-one;hydrochloride	Investigative	45260812	C19H22ClNO3	347.8	CN(C)CC(=C)C(=O)C1=CC(=C(C=C1)OCC2=CC=CC=C2)O.Cl	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BD1OI6	1,8-Naphthyridin-2(1H)-one deriv. 9h	Investigative	5328728	C23H27Cl2N5O	460.4	CN1CCN(CC1)CCCNC2=NC3=C(C=C2)C=C(C(=O)N3C)C4=C(C=CC=C4Cl)Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BD37MI	[4-[(2S)-2-Acetamido-3-[[(1S)-1-[3-(3-methylbutyl)-1,2,4-oxadiazol-5-yl]propyl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	44315949	C21H31N4O7P	482.5	CC[C@@H](C1=NC(=NO1)CCC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)OP(=O)(O)O)NC(=O)C	IC50 = 111000 nM	Poor binder
T85943	Proto-oncogene c-Src	BD6G5S	7-(3,5-Dimethoxyphenyl)-N-(2,3-dimethylphenyl)-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	59837673	C24H24N4O2	400.5	CC1=C(C(=CC=C1)NC2=NC3=C(C=C(C=C3C)C4=CC(=CC(=C4)OC)OC)N=N2)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BD6L3I	2-(4-((4-Amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-1-(thiophen-2-yl)ethanone	Investigative	53322861	C20H16N8OS	416.5	C1=CC=C(C=C1)C2=NN(C3=NC=NC(=C23)N)CC4=CN(N=N4)CC(=O)C5=CC=CS5	IC50 ~ 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BD7GQ4	1,6-Naphthyridine deriv. 19	Investigative	5329003	C26H34N6O4	494.6	CC(C)(C)NC(=O)NC1=CC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BDAR08	3-[4-(3-Amino-7-methoxy-1,2-benzoxazol-4-yl)phenyl]-1-(3-chlorophenyl)urea	Investigative	11429729	C21H17ClN4O3	408.8	COC1=C2C(=C(C=C1)C3=CC=C(C=C3)NC(=O)NC4=CC(=CC=C4)Cl)C(=NO2)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BDE36L	1,2,4-Oxadiazole Analogue 10	Investigative	5329202	C31H29F3N5O7P	671.6	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C4=NC(=NO4)CC5=CC=C(C=C5)C(F)(F)F	IC50 = 92000 nM	Poor binder
T85943	Proto-oncogene c-Src	BDG2H1	3',6-Diamino-7-hydroxyflavone	Investigative	10265006	C15H12N2O3	268.27	C1=CC(=CC(=C1)N)C2=CC(=O)C3=CC(=C(C=C3O2)O)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BDGW97	2-(4-Methylpiperazin-1-yl)ethyl N-(3-bromophenyl)-N-[6-methylsulfanyl-1-(2-phenylpropyl)pyrazolo[3,4-d]pyrimidin-4-yl]carbamate	Investigative	71762922	C29H34BrN7O2S	624.6	CC(CN1C2=C(C=N1)C(=NC(=N2)SC)N(C3=CC(=CC=C3)Br)C(=O)OCCN4CCN(CC4)C)C5=CC=CC=C5	Ki ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BDI94T	(2S,3S)-2-{(S)-2-[(S)-2-((S)-2-Amino-3-phenyl-propionylamino)-4-carboxy-butyrylamino]-4-carboxy-1-oxo-butylamino}-3-methyl-pentanoic acid	Investigative	44404626	C25H36N4O9	536.6	CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BDK7G3	6-Methoxy-3-phenylbenzimidazole-5-carbaldehyde	Investigative	5328534	C15H12N2O2	252.27	COC1=CC2=C(C=C1C=O)N(C=N2)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BDK9R0	Calicoferol C	Investigative	10024683	C28H44O2	412.6	CC1=C(C=C(C=C1)O)CC[C@H]2[C@@H]3CC[C@@H]([C@]3(CC[C@H]2O)C)[C@H](C)CCC(=C)C(C)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BDO1L8	1-(4-Phenylmethoxyphenyl)-2-(piperazin-1-ylmethyl)prop-2-en-1-one;hydrochloride	Investigative	45260839	C21H25ClN2O2	372.9	C=C(CN1CCNCC1)C(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BDV56G	Bisindolylmaleimide xi, HCl	Investigative	11605551	C28H29ClN4O2	489	CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C5CC(CCN5C6=CC=CC=C64)CN(C)C.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BE3L7O	(2S,3R)-2-[[(3S)-3-[[(2S)-2-[[(2S)-2-Acetamido-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-carboxypropanoyl]amino]-3-methylpentanoic acid	Investigative	56675105	C26H37N4O14P	660.6	CC[C@@H](C)[C@@H](C(=O)O)NC(=O)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C	IC50 = 90700 nM	Poor binder
T85943	Proto-oncogene c-Src	BE4TD1	2-(4-p-Tolyl-1H-1,2,3-triazol-1-yl)cyclopentanone	Investigative	53321269	C14H15N3O	241.29	CC1=CC=C(C=C1)C2=CN(N=N2)C3CCCC3=O	IC50 = 62100 nM	Poor binder
T85943	Proto-oncogene c-Src	BE4V9G	N-((5-Methoxy-1H-indol-3-yl)(4-methoxyphenyl)methyl)-Nmethylbenzenamine	Investigative	54581588	C24H24N2O2	372.5	CN(C1=CC=CC=C1)C(C2=CC=C(C=C2)OC)C3=CNC4=C3C=C(C=C4)OC	IC50 = 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BE5CD3	4',8-Diamino-6-methoxyflavone	Investigative	10085171	C16H14N2O3	282.29	COC1=CC2=C(C(=C1)N)OC(=CC2=O)C3=CC=C(C=C3)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BE68NP	1-(4-Chlorophenyl)-2-(4-phenyl-1H-1,2,3-triazol-1-yl)ethanone	Investigative	46742606	C16H12ClN3O	297.74	C1=CC=C(C=C1)C2=CN(N=N2)CC(=O)C3=CC=C(C=C3)Cl	IC50 = 139000 nM	Poor binder
T85943	Proto-oncogene c-Src	BE6UC9	2,2-Dihydroxy-3-oxo-3-phenylpropionic acid methyl ester	Investigative	10081832	C10H10O5	210.18	COC(=O)C(C(=O)C1=CC=CC=C1)(O)O	IC50 = 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BE9MA7	4-Cyano-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	10111108	C23H16N6O	392.4	C1=CC(=CC(=C1)NC(=O)C2=CC=C(C=C2)C#N)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BE9NM8	[4-[(2S)-2-Acetamido-3-[[(1S)-1-[3-(cyclohexylmethyl)-1,2,4-oxadiazol-5-yl]-2-(1H-indol-3-yl)ethyl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	44315638	C30H36N5O7P	609.6	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C4=NC(=NO4)CC5CCCCC5	IC50 = 62000 nM	Poor binder
T85943	Proto-oncogene c-Src	BEH3J0	[4-[[(3R,6S,9R,12S,18R)-6-(2-Amino-2-oxoethyl)-2,5,8,11,14,17-hexaoxo-3,9-di(propan-2-yl)-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44386412	C30H44N7O11P	709.7	CC(C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)C(C)C)CC(=O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BEJ7T3	7-(3,5-Dimethoxyphenyl)-5-methyl-N-pyridin-4-yl-1,2,4-benzotriazin-3-amine	Investigative	59837708	C21H19N5O2	373.4	CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=NC=C3)C4=CC(=CC(=C4)OC)OC	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BEYR24	1,2,4-Oxadiazole Analogue 12e	Investigative	5329205	C22H24FN4O8P	522.4	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CO)C2=NC(=NO2)CC3=CC=C(C=C3)F	IC50 = 132000 nM	Poor binder
T85943	Proto-oncogene c-Src	BF13ML	4-(4-Fluorophenyl)-2-phenyl-5-pyridin-4-ylpyrazol-3-amine	Investigative	56950881	C20H15FN4	330.4	C1=CC=C(C=C1)N2C(=C(C(=N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)N	IC50 = 52000 nM	Poor binder
T85943	Proto-oncogene c-Src	BF1X7G	(2S,3R)-2-[[(2S)-2-[[(4S)-4-[[(2S)-2-Acetamido-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoic acid	Investigative	56657889	C27H39N4O14P	674.6	CC[C@@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C	IC50 = 69500 nM	Poor binder
T85943	Proto-oncogene c-Src	BF29UM	3-[(2S,5S,8S,11S,14S,17S,20S,23S)-8,14,20-Tris(2-carboxyethyl)-5,11,17,23-tetrakis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,18,21,24-octaoxo-1,4,7,10,13,16,19,22-octazacyclotetracos-2-yl]propanoic acid	Investigative	73350439	C44H76N20O16	1141.2	C(C[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCC(=O)O)CCCN=C(N)N)CCC(=O)O)CCCN=C(N)N)CCC(=O)O)CCCN=C(N)N)CCC(=O)O)CN=C(N)N	IC50 = 52600 nM	Poor binder
T85943	Proto-oncogene c-Src	BF32AR	Calicoferol B	Investigative	10047545	C27H44O3	416.6	CC1=C(C=C(C=C1)O)CC[C@@H]2[C@@H](CC[C@]3([C@H]2C[C@@H]([C@@H]3[C@H](C)CCCC(C)C)O)C)O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BF5M6P	2-(2-Methoxy-ethoxy)-N-{3-[5-(3-phenoxy-prop-1-ynyl)-thiophen-3-yl]-2,4-dihydro-indeno[1,2-c]pyrazol-5-yl}-acetamide	Investigative	44440256	C28H25N3O4S	499.6	COCCOCC(=O)NC1=CC=CC2=C1CC3=C2NN=C3C4=CSC(=C4)C#CCOC5=CC=CC=C5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BF6X2P	2-(6-Amino-7H-purine-7-yl)-1-(1H-indole-3-yl)ethanone	Investigative	42604008	C15H12N6O	292.3	C1=CC=C2C(=C1)C(=CN2)C(=O)CN3C=NC4=NC=NC(=C43)N	IC50 = 82000 nM	Poor binder
T85943	Proto-oncogene c-Src	BF85CX	2-(3-Chlorophenyl)-3-cyclohexyl-6,7-dihydro-5H-indazol-4-one	Investigative	57391517	C19H21ClN2O	328.8	C1CCC(CC1)C2=C3C(=NN2C4=CC(=CC=C4)Cl)CCCC3=O	IC50 = 58400 nM	Poor binder
T85943	Proto-oncogene c-Src	BFE2H7	N-Phenyl-4-(pyridin-3-yl)pyrimidin-2-amine	Investigative	11311217	C15H12N4	248.28	C1=CC=C(C=C1)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BFIW18	7,8-Dimethoxy-3-(2-morpholin-4-yl-ethyl)-5,10-dihydro-3H-pyrimido[4,5-b]quinolin-4-one	Investigative	44264208	C19H24N4O4	372.4	COC1=C(C=C2C(=C1)CC3=C(N2)N=CN(C3=O)CCN4CCOCC4)OC	IC50 = 105000 nM	Poor binder
T85943	Proto-oncogene c-Src	BFL57T	2-(2-Aminoethylsulfanylmethyl)-3-(dimethylamino)-1-(4-phenylmethoxyphenyl)propan-1-one;hydrochloride	Investigative	45260874	C21H29ClN2O2S	409	CN(C)CC(CSCCN)C(=O)C1=CC=C(C=C1)OCC2=CC=CC=C2.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BFO34B	(S)-2-((S)-3-{(S)-2-[2-Amino-3-(4-phosphonooxy-phenyl)-propionylamino]-4-carboxy-butyrylamino}-4-carboxy-butyrylamino)-3-methyl-butyric acid	Investigative	11331005	C24H35N4O13P	618.5	CC(C)[C@@H](C(=O)O)NC(=O)C[C@@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)N	IC50 = 76300 nM	Poor binder
T85943	Proto-oncogene c-Src	BFQ37Y	8-Chloro-4-(3-chloro-4-fluorophenylamino)-6-((1-(1-cyclobutylpiperidin-4-yl)-1H-1,2,3-triazol-4-yl)methylamino)quinoline-3-carbonitrile	Investigative	44143373	C28H27Cl2FN8	565.5	C1CC(C1)N2CCC(CC2)N3C=C(N=N3)CNC4=CC5=C(C(=CN=C5C(=C4)Cl)C#N)NC6=CC(=C(C=C6)F)Cl	IC50 = 110000 nM	Poor binder
T85943	Proto-oncogene c-Src	BFQ91C	5-Substituted 1-Phenylbenzimidazole 33	Investigative	5328523	C16H14N2O	250.29	C=CCC1=C(C=CC2=C1N=CN2C3=CC=CC=C3)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BFQA92	2-[4-[(4-Amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)methyl]triazol-1-yl]-N-(4-chlorophenyl)acetamide	Investigative	53317690	C22H18ClN9O	459.9	C1=CC=C(C=C1)C2=NN(C3=NC=NC(=C23)N)CC4=CN(N=N4)CC(=O)NC5=CC=C(C=C5)Cl	IC50 ~ 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BFW94A	Dithiobis(1H-indole-3-carboxamide) deriv. 10g	Investigative	5328598	C32H24Cl2N4O2S2	631.6	CN1C2=C(C=C(C=C2)Cl)C(=C1SSC3=C(C4=C(N3C)C=CC(=C4)Cl)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BFZ83U	3-(3,4-Dichlorophenyl)-2-(3-hydroxy-4-methoxyphenyl)-6,6-dimethyl-5,7-dihydroindazol-4-one	Investigative	57396826	C22H20Cl2N2O3	431.3	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC(=C(C=C4)OC)O)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BG0I1Y	Dithiobis(1H-indole-3-carboxamide) deriv. 10j	Investigative	5328601	C34H30N4O4S2	622.8	CN1C2=C(C=C(C=C2)OC)C(=C1SSC3=C(C4=C(N3C)C=CC(=C4)OC)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BG0IP9	(2E)-2-[(3,5-Dibromo-4-hydroxyphenyl)methylidene]-5-methoxyindene-1,3-dione	Investigative	10410849	C17H10Br2O4	438.1	COC1=CC2=C(C=C1)C(=O)/C(=C\\C3=CC(=C(C(=C3)Br)O)Br)/C2=O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BG0O4J	[4-[[(3S,6R,9S,12R,15R,22R)-15-Acetamido-6-(2-amino-2-oxoethyl)-2,5,8,11,14,21-hexaoxo-3,9-di(propan-2-yl)-1,4,7,10,13,20-hexazabicyclo[20.3.0]pentacosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44386635	C36H55N8O12P	822.8	CC(C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)NCCCC[C@H](C(=O)N[C@@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C)C(C)C)CC(=O)N	IC50 = 73000 nM	Poor binder
T85943	Proto-oncogene c-Src	BG4R6T	N-(3-Chlorophenyl)-9H-pyrimido[4,5-b]indol-4-amine	Investigative	9882602	C16H11ClN4	294.74	C1=CC=C2C(=C1)C3=C(N2)N=CN=C3NC4=CC(=CC=C4)Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BGB67A	(2S,3R)-2-[[(2S)-2-[[(3S)-3-[[(2S)-2-Amino-3-(4-phosphonooxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoic acid	Investigative	56661328	C24H35N4O13P	618.5	CC[C@@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BGOV48	(E)-3-(2-(6-(Cyclopropylamino)-9H-purin-9-yl)vinyl)-4-methyl-N-(2-fluoro-5-(trifluoromethyl)phenyl)benzamide	Investigative	44221730	C25H20F4N6O	496.5	CC1=C(C=C(C=C1)C(=O)NC2=C(C=CC(=C2)C(F)(F)F)F)/C=C/N3C=NC4=C(N=CN=C43)NC5CC5	IC50 = 86000 nM	Poor binder
T85943	Proto-oncogene c-Src	BGQ65L	7-Amino-3-decyl-4-methylchromen-2-one	Investigative	122188441	C20H29NO2	315.4	CCCCCCCCCCC1=C(C2=C(C=C(C=C2)N)OC1=O)C	IC50 = 73500 nM	Poor binder
T85943	Proto-oncogene c-Src	BH2R5E	{(S)-2-[4-(Benzyloxy-hydroxy-phosphoryloxy)-phenyl]-1-[5-(3-cyclohexyl-propyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylcarbamoyl]-ethyl}-carbamic acid tert-butyl ester	Investigative	44307626	C39H50N3O8PS	751.9	CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)OCC2=CC=CC=C2)C(=O)NC3CSC4=CC=CC=C4N(C3=O)CCCC5CCCCC5	IC50 = 87000 nM	Poor binder
T85943	Proto-oncogene c-Src	BH49AC	1-(4-Chlorophenyl)-2-(4-p-tolyl-1H-1,2,3-triazol-1-yl)ethanone	Investigative	53326498	C17H14ClN3O	311.8	CC1=CC=C(C=C1)C2=CN(N=N2)CC(=O)C3=CC=C(C=C3)Cl	IC50 = 108700 nM	Poor binder
T85943	Proto-oncogene c-Src	BHJ0C6	7-(3,5-Dimethoxyphenyl)-N-(4-methoxyphenyl)-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	59837757	C23H22N4O3	402.4	CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=C(C=C3)OC)C4=CC(=CC(=C4)OC)OC	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BHQ9D8	3-(3,4-Dichlorophenyl)-2-(4-hydroxyphenyl)-6,6-dimethyl-5,7-dihydroindazol-4-one	Investigative	57393342	C21H18Cl2N2O2	401.3	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=C(C=C4)O)C	IC50 = 66600 nM	Poor binder
T85943	Proto-oncogene c-Src	BHS9J8	1-(4-(1-(2-(4-Amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-1H-1,2,3-triazol-4-yl)phenyl)ethanone	Investigative	53322858	C23H20N8O	424.5	CC(=O)C1=CC=C(C=C1)C2=CN(N=N2)CCN3C4=NC=NC(=C4C(=N3)C5=CC=CC=C5)N	IC50 ~ 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BI01FU	5-Methylsulfanyl-1-phenylbenzimidazole	Investigative	5328514	C14H12N2S	240.33	CSC1=CC2=C(C=C1)N(C=N2)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BI0J6M	4-Chloro-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	9953676	C23H18ClN5O	415.9	CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)Cl)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BI2VA4	3-[4-(4-Hydroxyphenyl)phenyl]-N-(pyridin-4-ylmethyl)-1,4-dihydroindeno[1,2-c]pyrazole-6-carboxamide	Investigative	136060555	C29H22N4O2	458.5	C1C2=C(C=CC(=C2)C(=O)NCC3=CC=NC=C3)C4=C1C(=NN4)C5=CC=C(C=C5)C6=CC=C(C=C6)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BI4N2C	(2S,3S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-N-[(2S)-1-[[(3S,6S,9S)-3,6-bis[(4-hydroxyphenyl)methyl]-2,5,8-trioxo-1,4,7-triazacyclotridec-9-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-3-methylpentanamide	Investigative	11614881	C44H57N7O10S	876	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@H]2CCCCNC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CC3=CC=C(C=C3)O)CC4=CC=C(C=C4)O)NC(=O)[C@H](CS)NC(=O)C	IC50 = 54500 nM	Poor binder
T85943	Proto-oncogene c-Src	BI5OH4	7-(3,5-Dimethyl-1,2-oxazol-4-yl)-N-[4-[2-(1,4-dimethylpiperazin-1-ium-1-yl)ethoxy]phenyl]-5-methyl-1,2,4-benzotriazin-3-amine;2,2,2-trifluoroacetate	Investigative	71179178	C29H34F3N7O4	601.6	CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=C(C=C3)OCC[N+]4(CCN(CC4)C)C)C5=C(ON=C5C)C.C(=O)(C(F)(F)F)[O-]	IC50 = 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BI6S5B	1-Propanone, 3-(4-morpholinyl)-1-(4-(phenylmethoxy)phenyl)-, hydrochloride	Investigative	2807057	C20H24ClNO3	361.9	C1COCCN1CCC(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BIC9Y6	BrC=1C=C(C=CC=1)N(C(OCCN1CCN(CC1)C)=O)C1=C2C(=NC(=N1)SCCN1CCOCC1)N(N=C2)CC(C1=CC=CC=C1)Cl	Investigative	121316022	C33H40BrClN8O3S	744.1	CN1CCN(CC1)CCOC(=O)N(C2=CC(=CC=C2)Br)C3=NC(=NC4=C3C=NN4CC(C5=CC=CC=C5)Cl)SCCN6CCOCC6	Ki ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BIKV80	3-[[2-(2-Fluorophenyl)pyridin-4-yl]amino]-4-[[(1R)-1-phenylethyl]amino]cyclobut-3-ene-1,2-dione	Investigative	44575073	C23H18FN3O2	387.4	C[C@H](C1=CC=CC=C1)NC2=C(C(=O)C2=O)NC3=CC(=NC=C3)C4=CC=CC=C4F	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BIL2W6	4',8-Diamino-5-methoxyflavone	Investigative	10468973	C16H14N2O3	282.29	COC1=C2C(=O)C=C(OC2=C(C=C1)N)C3=CC=C(C=C3)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BIN34L	[4-[(2S)-2-Acetamido-3-[[(1S)-2-(1H-indol-3-yl)-1-[3-(4-methylpentyl)-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	44315714	C29H36N5O7P	597.6	CC(C)CCCC1=NOC(=N1)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)OP(=O)(O)O)NC(=O)C	IC50 = 89000 nM	Poor binder
T85943	Proto-oncogene c-Src	BIR3H1	3-(4'-Hydroxybiphenyl-4-Yl)-N-(4-Hydroxycyclohexyl)-1,4-Dihydroindeno[1,2-C]pyrazole-6-Carboxamide	Investigative	135589980	C29H27N3O3	465.5	C1CC(CCC1NC(=O)C2=CC3=C(C=C2)C4=C(C3)C(=NN4)C5=CC=C(C=C5)C6=CC=C(C=C6)O)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BISD62	3-(3,4-Dichlorophenyl)-2-(4-nitrophenyl)-6,7-dihydro-5H-indazol-4-one	Investigative	57396743	C19H13Cl2N3O3	402.2	C1CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=C(C=C4)[N+](=O)[O-]	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BIU6D3	(S)-4-[(S)-2-((1S,4S)-2-Amino-3-methyl-pentanoylamino)-4-carboxy-1-oxo-butylamino]-4-((S)-1-carboxy-2-phenyl-ethylcarbamoyl)-butyric acid	Investigative	44404627	C25H36N4O9	536.6	CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BIW68Z	7-(2-Chlorophenyl)-5-methyl-N-phenyl-1,2,4-benzotriazin-3-amine	Investigative	11609923	C20H15ClN4	346.8	CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=CC=C3)C4=CC=CC=C4Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJ10YL	5-[(3,4-Dichlorophenyl)methyl]-2,3,7,8-tetrahydroxyphenanthridin-6-one	Investigative	5328660	C20H13Cl2NO5	418.2	C1=CC(=C(C=C1CN2C3=CC(=C(C=C3C4=C(C2=O)C(=C(C=C4)O)O)O)O)Cl)Cl	IC50 = 197000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJ18GQ	N-((5-Bromo-1H-indol-3-yl)(p-tolyl)methyl)-N-methylbenzenamine	Investigative	53358312	C23H21BrN2	405.3	CC1=CC=C(C=C1)C(C2=CNC3=C2C=C(C=C3)Br)N(C)C4=CC=CC=C4	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJ3X7A	1,2,4-Oxadiazole Analogue 5h	Investigative	6326456	C22H24FN4O7P	506.4	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 200000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJ4VC0	4-(3-Chlorophenylamino)-5,6-dimethyl-7H-pyrrolo(2,3-d)pyrimidine	Investigative	9816954	C14H13ClN4	272.73	CC1=C(NC2=C1C(=NC=N2)NC3=CC(=CC=C3)Cl)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJ86SW	1-[2-Amino-6-(3,5-diethylphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea	Investigative	5329126	C22H28N6O	392.5	CCC1=CC(=CC(=C1)C2=C(N=C3C(=C2)C=NC(=N3)N)NC(=O)NC(C)(C)C)CC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJ87UM	Src SH2 inhibitor, 4	Investigative	10812007	C21H26NO6P	419.4	C1CCC(CC1)COC2=CC=C(C=C2)CNC(=O)C3=CC=C(C=C3)OP(=O)(O)O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJ90SX	1-[7-Amino-3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-yl]-3-methylurea	Investigative	5328997	C18H19N5O3	353.4	CNC(=O)NC1=C(C=C2C=NC(=CC2=N1)N)C3=CC(=CC(=C3)OC)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJ98NZ	2-(4-Phenyl-1H-1,2,3-triazol-1-yl)cyclopentanone	Investigative	53326500	C13H13N3O	227.26	C1CC(C(=O)C1)N2C=C(N=N2)C3=CC=CC=C3	IC50 = 105500 nM	Poor binder
T85943	Proto-oncogene c-Src	BJ9E6Q	2-(6-Amino-9H-purin-9-yl)-1-(pyridin-3-yl)ethanone	Investigative	42603881	C12H10N6O	254.25	C1=CC(=CN=C1)C(=O)CN2C=NC3=C(N=CN=C32)N	IC50 = 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJD2T1	3-(4-(2-(4-Phenyl-1H-1,2,3-triazol-1-yl)acetyl)phenyl)-2H-chromen-2-one	Investigative	53317358	C25H17N3O3	407.4	C1=CC=C(C=C1)C2=CN(N=N2)CC(=O)C3=CC=C(C=C3)C4=CC5=CC=CC=C5OC4=O	IC50 = 89500 nM	Poor binder
T85943	Proto-oncogene c-Src	BJH84B	1,2,4-Oxadiazole Analogue 12c	Investigative	5329221	C26H27N4O8P	554.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CO)C2=NC(=NO2)CC3=CC4=CC=CC=C4C=C3	IC50 = 99000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJI36Z	(2R,3S,4R,5S)-2-(Hydroxymethyl)-5-(4-phenylphenoxy)oxolane-3,4-diol	Investigative	71450495	C17H18O5	302.32	C1=CC=C(C=C1)C2=CC=C(C=C2)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	IC50 = 125000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJQ64G	1,2,4-Oxadiazole Analogue 12a	Investigative	5329204	C22H24ClN4O8P	538.9	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CO)C2=NC(=NO2)CC3=CC=C(C=C3)Cl	IC50 = 149000 nM	Poor binder
T85943	Proto-oncogene c-Src	BJUX64	3-(3-Chloro-phenyl)-5-hydroxy-7-methoxy-chromen-4-one	Investigative	10590515	C16H11ClO4	302.71	COC1=CC(=C2C(=C1)OC=C(C2=O)C3=CC(=CC=C3)Cl)O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BK1V8Q	3-{[2-(2-Furyl)pyridin-4-yl]amino}-4-{[(1R)-1-phenylethyl]amino}cyclobut-3-ene-1,2-dione	Investigative	44575126	C21H17N3O3	359.4	C[C@H](C1=CC=CC=C1)NC2=C(C(=O)C2=O)NC3=CC(=NC=C3)C4=CC=CO4	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BK2GQ1	N-Benzyl-N-methyl-4-(phenylsulfamoyl)benzamide	Investigative	27666048	C21H20N2O3S	380.5	CN(CC1=CC=CC=C1)C(=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BK2ZN9	3-(3,4-Dichlorophenyl)-2-(4-methoxyphenyl)-6,6-dimethyl-5,7-dihydroindazol-4-one	Investigative	57402051	C22H20Cl2N2O2	415.3	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=C(C=C4)OC)C	IC50 = 94100 nM	Poor binder
T85943	Proto-oncogene c-Src	BK3FD0	3-(1-Phenylbenzimidazol-5-yl)oxypropane-1,2-diol	Investigative	5328504	C16H16N2O3	284.31	C1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)OCC(CO)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BK4HI8	7-(3,5-Dimethoxyphenyl)-5-methyl-N-(3-methylphenyl)-1,2,4-benzotriazin-3-amine	Investigative	59837703	C23H22N4O2	386.4	CC1=CC(=CC=C1)NC2=NC3=C(C=C(C=C3C)C4=CC(=CC(=C4)OC)OC)N=N2	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BK5V1Q	4',8-Diamino-7-hydroxyflavone	Investigative	10423146	C15H12N2O3	268.27	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3)O)N)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BKA74D	1,2,4-Benzotriazin-3-amine,7-(2-chlorophenyl)-5-methyl-	Investigative	24822755	C14H11ClN4	270.72	CC1=CC(=CC2=C1N=C(N=N2)N)C3=CC=CC=C3Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BKC32X	[4-[[(3S,6R,9S,12R,15S,22R)-15-Acetamido-6-(2-amino-2-oxoethyl)-9-(2-methylpropyl)-2,5,8,11,14,21-hexaoxo-3-propan-2-yl-1,4,7,10,13,20-hexazabicyclo[20.3.0]pentacosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44386411	C37H57N8O12P	836.9	CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C)C(C)C)CC(=O)N	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BKGE82	1 H-Indole-3-alkanamide deriv. 10m	Investigative	5328581	C40H38N4O8S2	766.9	COC(=O)C1=C(C=C(C=C1)CNC(=O)CCC2=C(NC3=CC=CC=C32)SSC4=C(C5=CC=CC=C5N4)CCC(=O)NCC6=CC(=C(C=C6)C(=O)OC)O)O	IC50 = 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BKJZ57	1-[2-Amino-6-(3,4-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea	Investigative	5329130	C20H24N6O3	396.4	CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=CC(=C(C=C3)OC)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BKL1O8	N-(3-Bromophenyl)-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine	Investigative	10615400	C14H13BrN4	317.18	CC1=C(NC2=C1C(=NC=N2)NC3=CC(=CC=C3)Br)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BKQ0H4	2-(4-Methyl-piperazin-1-yl)-N-{3-[5-(3-phenoxy-prop-1-ynyl)-thiophen-3-yl]-2,4-dihydro-indeno[1,2-c]pyrazol-5-yl}-acetamide	Investigative	16747696	C30H29N5O2S	523.6	CN1CCN(CC1)CC(=O)NC2=CC=CC3=C2CC4=C3NN=C4C5=CSC(=C5)C#CCOC6=CC=CC=C6	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BL27SC	3-[1-(1-Methyl-piperidin-4-yl)-indol-3-yl]-4-(1-methyl-indol-3-yl)-1H-pyrrole-2,5-dione	Investigative	9889351	C27H26N4O2	438.5	CN1CCC(CC1)N2C=C(C3=CC=CC=C32)C4=C(C(=O)NC4=O)C5=CN(C6=CC=CC=C65)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BL5WS8	1,8-Naphthyridin-2(1H)-one deriv. 9n	Investigative	5328729	C21H15Cl2N3O	396.3	CN1C2=C(C=CC(=N2)NC3=CC=CC=C3)C=C(C1=O)C4=C(C=CC=C4Cl)Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BL69NQ	N-((5-Methoxy-1H-indol-3-yl)(p-tolyl)methyl)-N-methylbenzenamine	Investigative	53358311	C24H24N2O	356.5	CC1=CC=C(C=C1)C(C2=CNC3=C2C=C(C=C3)OC)N(C)C4=CC=CC=C4	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BLJO35	Dithiobis(1H-indole-3-carboxamide) deriv. 10u	Investigative	5328612	C32H24Cl2N4O2S2	631.6	CN1C2=C(C=CC=C2Cl)C(=C1SSC3=C(C4=C(N3C)C(=CC=C4)Cl)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BLW8T3	1-[2-Amino-6-(4-methoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea	Investigative	5329129	C19H22N6O2	366.4	CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=CC=C(C=C3)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BM51KZ	Caftaric acid	Investigative	6440397	C13H12O9	312.23	C1=CC(=C(C=C1/C=C/C(=O)O[C@H]([C@H](C(=O)O)O)C(=O)O)O)O	IC50 = 74000 nM	Poor binder
T85943	Proto-oncogene c-Src	BM5NV2	1-Phenyl-5-propan-2-yloxybenzimidazole	Investigative	5328499	C16H16N2O	252.31	CC(C)OC1=CC2=C(C=C1)N(C=N2)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BM8Q3B	N-[4-Methyl-3-[(E)-2-[6-(methylamino)purin-9-yl]ethenyl]phenyl]-3-(trifluoromethyl)benzamide	Investigative	15950818	C23H19F3N6O	452.4	CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)/C=C/N3C=NC4=C(N=CN=C43)NC	IC50 = 52000 nM	Poor binder
T85943	Proto-oncogene c-Src	BMD60V	7-(2,6-Dimethylphenyl)-5-methyl-N-(pyridin-2-yl)benzo[e][1,2,4]triazin-3-amine	Investigative	11595313	C21H19N5	341.4	CC1=C(C(=CC=C1)C)C2=CC3=C(C(=C2)C)N=C(N=N3)NC4=CC=CC=N4	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BMF38Y	N-[3-[(4-Pyridin-3-ylpyrimidin-2-yl)amino]phenyl]pyridine-2-carboxamide	Investigative	11280103	C21H16N6O	368.4	C1=CC=NC(=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 = 90000 nM	Poor binder
T85943	Proto-oncogene c-Src	BMHZ45	4',8-Diaminoflavone	Investigative	10264200	C15H12N2O2	252.27	C1=CC2=C(C(=C1)N)OC(=CC2=O)C3=CC=C(C=C3)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BMP0C7	Tert-Butyl 4-(6-(4-aminophenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate	Investigative	44605037	C25H33N7O3	479.6	CC(C)(C)OC(=O)N1CCC(CC1)N2C3=C(C=N2)C(=NC(=N3)C4=CC=C(C=C4)N)N5CCOCC5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BMTS94	6-Methyl-4-(4-methyl-1H-indol-5-ylamino)-5-(3-(4-methylpiperazin-1-ylsulfonyl)styryl)nicotinonitrile	Investigative	45375866	C29H30N6O2S	526.7	CC1=C(C=CC2=C1C=CN2)NC3=C(C(=NC=C3C#N)C)/C=C/C4=CC(=CC=C4)S(=O)(=O)N5CCN(CC5)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BN52HJ	3-(2,6-Dichlorophenyl)-7-(dimethylamino)-1-methyl-1,6-naphthyridin-2-one	Investigative	5328702	C17H15Cl2N3O	348.2	CN1C2=CC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)N(C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BN9L2H	1-(2-(4-Heptyl-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	53324181	C22H28N8	404.5	CCCCCCCC1=CN(N=N1)CCN2C3=NC=NC(=C3C(=N2)C4=CC=CC=C4)N	IC50 ~ 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BNHC98	2-{[3,4-Dioxo-2-(pyridin-4-ylamino)cyclobut-1-en-1-yl]amino}-2-phenylacetamide	Investigative	25206064	C17H14N4O3	322.32	C1=CC=C(C=C1)C(C(=O)N)NC2=C(C(=O)C2=O)NC3=CC=NC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BNLS21	4',8-Diamino-5-hydroxyflavone	Investigative	10355659	C15H12N2O3	268.27	C1=CC(=CC=C1C2=CC(=O)C3=C(C=CC(=C3O2)N)O)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BNR6V2	[4-[[(3S,6R,9S,12R,15S,22R)-15-Acetamido-6-(2-amino-2-oxoethyl)-2,5,8,11,14,21-hexaoxo-3,9-di(propan-2-yl)-1,4,7,10,13,20-hexazabicyclo[20.3.0]pentacosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44386472	C36H55N8O12P	822.8	CC(C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C)C(C)C)CC(=O)N	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BNV3U4	5-Methoxy-6-methyl-1-phenylbenzimidazole	Investigative	5328528	C15H14N2O	238.28	CC1=CC2=C(C=C1OC)N=CN2C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BNY5V4	4-(4-Fluorophenyl)-1-(4-nitrophenyl)-3-(pyridin-4-yl)-1H-pyrazol-5-amine	Investigative	56950884	C20H14FN5O2	375.4	C1=CC(=CC=C1C2=C(N(N=C2C3=CC=NC=C3)C4=CC=C(C=C4)[N+](=O)[O-])N)F	IC50 = 82000 nM	Poor binder
T85943	Proto-oncogene c-Src	BO07MS	N-(4-Butylphenyl)-7-(2,6-dimethylphenyl)-5-methylbenzo[e][1,2,4]triazin-3-amine	Investigative	11696909	C26H28N4	396.5	CCCCC1=CC=C(C=C1)NC2=NC3=C(C=C(C=C3C)C4=C(C=CC=C4C)C)N=N2	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BO25WR	N-[3-(4-Pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-isonicotinamide	Investigative	11474111	C21H16N6O	368.4	C1=CC(=CC(=C1)NC(=O)C2=CC=NC=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 = 78000 nM	Poor binder
T85943	Proto-oncogene c-Src	BO34ZN	1-Ethyl-2-[[1-ethyl-3-(phenylcarbamoyl)indol-2-yl]disulfanyl]-N-phenylindole-3-carboxamide	Investigative	10483554	C34H30N4O2S2	590.8	CCN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3CC)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BO48KS	1-[2-Amino-6-(3,5-diethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea	Investigative	5329132	C22H28N6O3	424.5	CCOC1=CC(=CC(=C1)C2=C(N=C3C(=C2)C=NC(=N3)N)NC(=O)NC(C)(C)C)OCC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BO5P1D	N6,N6-Dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine	Investigative	6603857	C23H21N7	395.5	CN(C)C1=NC=C2C(=C1)C(=NC=N2)NC3=CC4=C(C=C3)N(N=C4)CC5=CC=CC=C5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BO5WT0	4-Methoxy-1-phenylbenzimidazol-5-ol	Investigative	5328519	C14H12N2O2	240.26	COC1=C(C=CC2=C1N=CN2C3=CC=CC=C3)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BO69ZP	[(S)-1-[4-(3-Cyclohexyl-propyl)-5-oxo-[1,4]thiazepan-6-ylcarbamoyl]-2-(4-phosphonooxy-phenyl)-ethyl]-carbamic acid tert-butyl ester	Investigative	44307740	C28H44N3O8PS	613.7	CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NC2CSCCN(C2=O)CCCC3CCCCC3	IC50 = 115000 nM	Poor binder
T85943	Proto-oncogene c-Src	BOA45D	3-(4-Ethoxy-3-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	Investigative	24905292	C14H15N5O2	285.3	CCOC1=C(C=C(C=C1)C2=C3C(=NC=NC3=NN2)N)OC	IC50 = 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BOFL73	6-(3,5-Dimethoxyphenyl)pyrido[2,3-d]pyrimidine-2,7-diamine	Investigative	5328126	C15H15N5O2	297.31	COC1=CC(=CC(=C1)C2=C(N=C3C(=C2)C=NC(=N3)N)N)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BORY71	(18S)-18-(Aminomethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione	Investigative	10527068	C26H24N4O3	440.5	C1CN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO[C@@H]1CN)C6=CC=CC=C65)C(=O)NC4=O	IC50 = 89000 nM	Poor binder
T85943	Proto-oncogene c-Src	BOSV19	7-(3,5-Dimethoxyphenyl)-5-methyl-N-(4-methylphenyl)-1,2,4-benzotriazin-3-amine	Investigative	59837590	C23H22N4O2	386.4	CC1=CC=C(C=C1)NC2=NC3=C(C=C(C=C3C)C4=CC(=CC(=C4)OC)OC)N=N2	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BP1B8S	[(S)-2-[4-(Benzyloxy-hydroxy-phosphoryloxy)-phenyl]-1-(2-(4-methoxy-phenyl)-5-{[(naphthalen-1-ylmethyl)-carbamoyl]-methyl}-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylcarbamoyl)-ethyl]-carbamic acid tert-butyl ester	Investigative	44307664	C50H51N4O10PS	931	CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)OCC2=CC=CC=C2)C(=O)NC3C(SC4=CC=CC=C4N(C3=O)CC(=O)NCC5=CC=CC6=CC=CC=C65)C7=CC=C(C=C7)OC	IC50 = 118000 nM	Poor binder
T85943	Proto-oncogene c-Src	BP85UX	1-Phenacyl-4-phenyl-1H-1,2,3-triazole	Investigative	16720859	C16H13N3O	263.29	C1=CC=C(C=C1)C2=CN(N=N2)CC(=O)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BPA1S3	PharmaGSID_48505	Investigative	86287525	C17H12ClN5O2	353.8	CC1=C2C(=NN1)NC3=C(C=C(C=C3)[N+](=O)[O-])C(=N2)C4=CC=CC=C4Cl	IC50 ~ 60000 nM	Poor binder
T85943	Proto-oncogene c-Src	BPCI51	1,2,4-Oxadiazole Analogue 13b	Investigative	5329224	C33H33N4O7P	628.6	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC2=CC=CC=C2)C3=NC(=NO3)CC4=CC5=CC=CC=C5C=C4	IC50 = 78000 nM	Poor binder
T85943	Proto-oncogene c-Src	BPCM01	N-((1H-Indol-3-yl)(4-methoxyphenyl)methyl)-N-methylbenzenamine	Investigative	54582578	C23H22N2O	342.4	CN(C1=CC=CC=C1)C(C2=CC=C(C=C2)OC)C3=CNC4=CC=CC=C43	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BPF61Y	4',6-Diamino-7-hydroxyflavone	Investigative	9970231	C15H12N2O3	268.27	C1=CC(=CC=C1C2=CC(=O)C3=CC(=C(C=C3O2)O)N)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BPN10E	(S)-4-[(S)-2-Acetylamino-3-(4-phosphonooxy-phenyl)-propionylamino]-4-[4-(3-methyl-butyl)-thiazol-2-yl]-butyric acid	Investigative	44315866	C23H32N3O8PS	541.6	CC(C)CCC1=CSC(=N1)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)OP(=O)(O)O)NC(=O)C	IC50 = 76000 nM	Poor binder
T85943	Proto-oncogene c-Src	BPQH98	(3-Chloro-phenyl)-(6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-4-yl)-amine	Investigative	9948215	C16H15ClN4	298.77	C1CCC2=C(C1)C3=C(N2)N=CN=C3NC4=CC(=CC=C4)Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BPS7O5	3-Cyclohexyl-6,6-dimethyl-2-(4-nitrophenyl)-5,7-dihydroindazol-4-one	Investigative	57401982	C21H25N3O3	367.4	CC1(CC2=NN(C(=C2C(=O)C1)C3CCCCC3)C4=CC=C(C=C4)[N+](=O)[O-])C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ1W5F	5-[4-Amino-1-(2,2-dimethoxyethyl)pyrazolo[3,4-d]pyrimidin-3-yl]-1,3-benzoxazol-2-amine	Investigative	127045861	C16H17N7O3	355.35	COC(CN1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N)OC	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ1Y4B	(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-m-tolyl-amine	Investigative	10848423	C15H16N4	252.31	CC1=CC(=CC=C1)NC2=NC=NC3=C2C(=C(N3)C)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ2Z1X	5-Substituted 1-Phenylbenzimidazole 34	Investigative	5328524	C16H14N2O	250.29	CC1CC2=C(O1)C=CC3=C2N=CN3C4=CC=CC=C4	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ3WY1	Dithiobis(1H-indole-3-carboxamide) deriv. 10h	Investigative	5328599	C32H24Br2N4O2S2	720.5	CN1C2=C(C=C(C=C2)Br)C(=C1SSC3=C(C4=C(N3C)C=CC(=C4)Br)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 = 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ4UI0	1H-Pyrazolo[3,4-d]pyrimidine-3,4-diamine, N,N'-diphenyl-	Investigative	5327823	C17H14N6	302.33	C1=CC=C(C=C1)NC2=C3C(=NN2)N=CN=C3NC4=CC=CC=C4	IC50 = 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ76IC	(2R)-2-[[(2S,3S)-4-[(E)-3-[(1R)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-enyl]-2-(3,4-dihydroxyphenyl)-6-hydroxy-2,3-dihydro-1-benzofuran-3-yl]-hydroxymethoxy]-3-(3,4-dihydroxyphenyl)propanoic acid	Investigative	45267045	C36H32O16	720.6	C1=CC(=C(C=C1C[C@H](C(=O)O)OC([C@@H]2[C@H](OC3=CC(=CC(=C23)/C=C/C(=O)O[C@H](CC4=CC(=C(C=C4)O)O)C(=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O	IC50 = 90000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ7D9N	N-((5-Bromo-1H-indol-3-yl)(4-methoxyphenyl)methyl)-N-methylaniline	Investigative	53358313	C23H21BrN2O	421.3	CN(C1=CC=CC=C1)C(C2=CC=C(C=C2)OC)C3=CNC4=C3C=C(C=C4)Br	IC50 = 106000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ7GM1	3-(4-Tert-butylphenyl)-2-(4-chlorophenyl)-6,6-dimethyl-5,7-dihydroindazol-4-one	Investigative	57400188	C25H27ClN2O	406.9	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC=C(C=C3)C(C)(C)C)C4=CC=C(C=C4)Cl)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ80FL	3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamine	Investigative	5328996	C16H16N4O2	296.32	COC1=CC(=CC(=C1)C2=C(N=C3C=C(N=CC3=C2)N)N)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ89GB	2-(4-Chlorophenyl)-3-(3,4-dichlorophenyl)-6,7-dihydro-5H-indazol-4-one	Investigative	57395223	C19H13Cl3N2O	391.7	C1CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl	IC50 = 81000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ8R5K	3-(3-Chloro-4-methylphenyl)-6,6-dimethyl-2-(1H-pyrrol-2-yl)-5,7-dihydroindazol-4-one	Investigative	57403737	C20H20ClN3O	353.8	CC1=C(C=C(C=C1)C2=C3C(=NN2C4=CC=CN4)CC(CC3=O)(C)C)Cl	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ8Z1T	[4-[[(3S,6R,9S,12R,15R,22R)-6-(2-Amino-2-oxoethyl)-15-(ethanethioylamino)-2,5,8,11,14,21-hexaoxo-3,9-di(propan-2-yl)-1,4,7,10,13,20-hexazabicyclo[20.3.0]pentacosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44385823	C36H55N8O11PS	838.9	CC(C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)NCCCC[C@H](C(=O)N[C@@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)NC(=S)C)C(C)C)CC(=O)N	IC50 = 88000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQ9Y5W	2-[9-(4-Amino-3-methoxyphenyl)-6-oxo-5,11-dihydrobenzo[b][1,4]benzodiazepin-3-yl]-N-(4-morpholin-4-ylphenyl)acetamide	Investigative	44427518	C32H31N5O4	549.6	COC1=C(C=CC(=C1)C2=CC3=C(C=C2)C(=O)NC4=C(N3)C=CC(=C4)CC(=O)NC5=CC=C(C=C5)N6CCOCC6)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQJ5M6	1,2,4-Oxadiazole Analogue 5c	Investigative	6326458	C22H24ClN4O7P	522.9	C[C@@H](C1=NC(=NO1)CC2=CC(=CC=C2)Cl)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 68000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQSW21	1,8-Naphthyridin-2(1H)-one deriv. 9e	Investigative	5328727	C22H26Cl2N4O	433.4	CCN(CC)CCCNC1=NC2=C(C=C1)C=C(C(=O)N2C)C3=C(C=CC=C3Cl)Cl	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BQTA68	PD158780 Analog 5n	Investigative	5328360	C19H21BrN6O	429.3	C1COCCN1CCNC2=NC=C3C(=C2)C(=NC=N3)NC4=CC(=CC=C4)Br	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BR1P6J	{(S)-2-[4-(Benzyloxy-hydroxy-phosphoryloxy)-phenyl]-1-[2-(4-methoxy-phenyl)-5-(naphthalen-1-ylcarbamoylmethyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylcarbamoyl]-ethyl}-carbamic acid tert-butyl ester	Investigative	44307444	C49H49N4O10PS	917	CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)OCC2=CC=CC=C2)C(=O)NC3C(SC4=CC=CC=C4N(C3=O)CC(=O)NC5=CC=CC6=CC=CC=C65)C7=CC=C(C=C7)OC	IC50 = 133000 nM	Poor binder
T85943	Proto-oncogene c-Src	BR4X5J	(3-Nitro-phenyl)-(4-pyridin-4-yl-pyrimidin-2-yl)-amine	Investigative	9814609	C15H11N5O2	293.28	C1=CC(=CC(=C1)[N+](=O)[O-])NC2=NC=CC(=N2)C3=CC=NC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BR4Z6X	N-(3-Chlorophenyl)-5-methyl-6-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine	Investigative	10568777	C19H15ClN4	334.8	CC1=C(NC2=C1C(=NC=N2)NC3=CC(=CC=C3)Cl)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BR62KQ	N-(2,3-Dimethylphenyl)-7-(2,6-dimethylphenyl)-5-methylbenzo[e][1,2,4]triazin-3-amine	Investigative	11675061	C24H24N4	368.5	CC1=C(C(=CC=C1)NC2=NC3=C(C=C(C=C3C)C4=C(C=CC=C4C)C)N=N2)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BR7UM2	N-(7-(2,6-Dimethylphenyl)-5-methylbenzo[e][1,2,4]triazin-3-yl)acetamide	Investigative	44419413	C18H18N4O	306.4	CC1=C(C(=CC=C1)C)C2=CC3=C(C(=C2)C)N=C(N=N3)NC(=O)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BR95ZN	N-(3,4-Dichlorophenyl)-7-(2,6-dimethylphenyl)-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	11661475	C22H18Cl2N4	409.3	CC1=C(C(=CC=C1)C)C2=CC3=C(C(=C2)C)N=C(N=N3)NC4=CC(=C(C=C4)Cl)Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BRCV74	PD089828 analog 12	Investigative	5329117	C20H18F6N6O	472.4	CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BRK74M	12-(4-Methoxyphenyl)-3,8-diphenyl-1,3,4,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-2(6),4,9,11-tetraen-7-one	Investigative	134143939	C25H18N6O2	434.4	COC1=CC=C(C=C1)C2=NN=C3N2C4=C(C=NN4C5=CC=CC=C5)C(=O)N3C6=CC=CC=C6	IC50 = 67000 nM	Poor binder
T85943	Proto-oncogene c-Src	BRN8J1	N-[3-(2-Pyridin-4-ylpyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-3-(trifluoromethyl)benzamide	Investigative	24822704	C25H16F3N5O	459.4	C1=CC(=CC(=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)C3=CC=NC4=CC(=NN34)C5=CC=NC=C5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BRT72U	N,alpha-Diphenyl-N-methyl-1H-indole-3-methaneamine	Investigative	53358198	C22H20N2	312.4	CN(C1=CC=CC=C1)C(C2=CC=CC=C2)C3=CNC4=CC=CC=C43	IC50 = 50600 nM	Poor binder
T85943	Proto-oncogene c-Src	BRV54M	Dithiobis(1H-indole-3-carboxamide) deriv. 10b	Investigative	5328593	C32H24Cl2N4O2S2	631.6	CN1C2=C(C(=CC=C2)Cl)C(=C1SSC3=C(C4=C(N3C)C=CC=C4Cl)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BRWP09	3',6-Diaminoflavone	Investigative	10264201	C15H12N2O2	252.27	C1=CC(=CC(=C1)N)C2=CC(=O)C3=C(O2)C=CC(=C3)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BS0W4I	7-((1H-1,2,4-Triazol-1-yl)methyl)-3-(5-(3-(2-methoxyethoxy)-prop-1-ynyl)thiophen-3-yl)-1,4-dihydroindeno[1,2-c]pyrazole	Investigative	11590078	C23H21N5O2S	431.5	COCCOCC#CC1=CC(=CS1)C2=NNC3=C2CC4=C3C=C(C=C4)CN5C=NC=N5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BS1L8A	2-(4-Hydroxyphenyl)-2-sulfoacetic acid	Investigative	3373694	C8H8O6S	232.21	C1=CC(=CC=C1C(C(=O)O)S(=O)(=O)O)O	IC50 = 190000 nM	Poor binder
T85943	Proto-oncogene c-Src	BS20CT	1,6-Naphthyridine deriv. 20	Investigative	5329004	C28H38N6O4	522.6	CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=CC2=N1)NCCCN3CCOCC3)C4=CC(=CC(=C4)OC)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BS2LC3	(3-Chloro-phenyl)-(5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine	Investigative	10692159	C24H17ClN4	396.9	C1=CC=C(C=C1)C2=C(NC3=C2C(=NC=N3)NC4=CC(=CC=C4)Cl)C5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BS3Q2G	N-((4-Chlorophenyl)(5-methoxy-1H-indol-3-yl)methyl)-N-methylbenzenamine	Investigative	53358310	C23H21ClN2O	376.9	CN(C1=CC=CC=C1)C(C2=CC=C(C=C2)Cl)C3=CNC4=C3C=C(C=C4)OC	IC50 = 87000 nM	Poor binder
T85943	Proto-oncogene c-Src	BSA3J9	[(S)-1-[5-(3-Cyclohexyl-propyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylcarbamoyl]-2-(4-hydroxy-phenyl)-ethyl]-carbamic acid tert-butyl ester	Investigative	44307619	C39H49N3O6S	687.9	CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NC2C(SC3=CC=CC=C3N(C2=O)CCCC4CCCCC4)C5=CC=C(C=C5)OC	IC50 = 164000 nM	Poor binder
T85943	Proto-oncogene c-Src	BSE2B9	1,2,4-Oxadiazole Analogue 13a	Investigative	5329223	C30H30F3N4O7P	646.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC2=CC=CC=C2)C3=NC(=NO3)CC4=CC=C(C=C4)C(F)(F)F	IC50 = 95000 nM	Poor binder
T85943	Proto-oncogene c-Src	BSM0W8	(S)-4-[(S)-2-((2S,3S)-2-Amino-3-methyl-pentanoylamino)-4-carboxy-butyrylamino]-4-[(S)-1-carboxy-2-(4-phosphonooxy-phenyl)-ethylcarbamoyl]-butyric acid	Investigative	44404624	C25H37N4O13P	632.6	CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BSN2Q3	Diguanosine tetraphosphate	Investigative	135398585	C20H28N10O21P4	868.4	C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C5N=C(NC6=O)N)O)O)O)O)N=C(NC2=O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BSR32G	(3Z)-6-(4-Hydroxy-3-methoxyphenyl)-3-(1H-imidazol-2-ylmethylidene)-2,3-dihydro-1H-indol-2-one	Investigative	135678111	C19H15N3O3	333.3	COC1=C(C=CC(=C1)C2=CC3=C(C=C2)/C(=C/C4=NC=CN4)/C(=O)N3)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BSX68U	1,6-Naphthyridine deriv. 16	Investigative	5329000	C23H21N5O3	415.4	COC1=CC(=CC(=C1)C2=C(N=C3C=C(N=CC3=C2)N)NC(=O)NC4=CC=CC=C4)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BT0V7B	5-[4-Amino-1-(1,3-dioxolan-2-ylmethyl)pyrazolo[3,4-d]pyrimidin-3-yl]-1,3-benzoxazol-2-amine	Investigative	127046862	C16H15N7O3	353.34	C1COC(O1)CN2C3=NC=NC(=C3C(=N2)C4=CC5=C(C=C4)OC(=N5)N)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BT2MA5	3-[4-(3-Amino-7-methoxy-1,2-benzoxazol-4-yl)phenyl]-1-[3-(trifluoromethyl)phenyl]urea	Investigative	11374110	C22H17F3N4O3	442.4	COC1=C2C(=C(C=C1)C3=CC=C(C=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F)C(=NO2)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BT43HG	4-(4-Fluorophenyl)-2-(4-methylphenyl)-5-pyridin-4-ylpyrazol-3-amine	Investigative	56950885	C21H17FN4	344.4	CC1=CC=C(C=C1)N2C(=C(C(=N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)N	IC50 = 53000 nM	Poor binder
T85943	Proto-oncogene c-Src	BT45WY	4-Methyl-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	9822042	C24H21N5O	395.5	CC1=CC=C(C=C1)C(=O)NC2=CC(=C(C=C2)C)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BT49GX	3-(3,4-Dichlorophenyl)-2-thiophen-2-yl-6,7-dihydro-5H-indazol-4-one	Investigative	57400250	C17H12Cl2N2OS	363.3	C1CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CS4	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BT59FK	N-[3-[(E)-2-[6-[3-(Dimethylamino)propylamino]purin-9-yl]ethenyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide	Investigative	44221727	C27H28F3N7O	523.6	CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)/C=C/N3C=NC4=C(N=CN=C43)NCCCN(C)C	IC50 = 159000 nM	Poor binder
T85943	Proto-oncogene c-Src	BT6J5C	(S)-4-[(S)-2-Acetylamino-3-(4-phosphonooxy-phenyl)-propionylamino]-4-(3-isobutyl-[1,2,4]oxadiazol-5-yl)-butyric acid	Investigative	44315810	C21H29N4O9P	512.4	CC(C)CC1=NOC(=N1)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)OP(=O)(O)O)NC(=O)C	IC50 = 166000 nM	Poor binder
T85943	Proto-oncogene c-Src	BT9FO8	1-(4-Phenylmethoxyphenyl)-2-(piperidin-1-ylmethyl)prop-2-en-1-one;hydrochloride	Investigative	45260884	C22H26ClNO2	371.9	C=C(CN1CCCCC1)C(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BTA3E0	4-Bromo-1-phenylbenzimidazol-5-ol	Investigative	5328521	C13H9BrN2O	289.13	C1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3Br)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BTB83M	N,N-Dimethyl-4-(1-phenylbenzimidazol-5-yl)oxybutan-1-amine	Investigative	5328508	C19H23N3O	309.4	CN(C)CCCCOC1=CC2=C(C=C1)N(C=N2)C3=CC=CC=C3	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BTF2Y1	4',6,8-Triaminoflavone	Investigative	10038606	C15H13N3O2	267.28	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=CC(=C3)N)N)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BTJC19	2-(4-((4-Amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-1-p-tolylethanone	Investigative	53322860	C23H20N8O	424.5	CC1=CC=C(C=C1)C(=O)CN2C=C(N=N2)CN3C4=NC=NC(=C4C(=N3)C5=CC=CC=C5)N	IC50 ~ 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BTL9X5	1-Propanone, 3-(dimethylamino)-1-(4-(phenylmethoxy)phenyl)-, hydrochloride	Investigative	3039850	C18H22ClNO2	319.8	CN(C)CCC(=O)C1=CC=C(C=C1)OCC2=CC=CC=C2.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BTYG57	AC-Dopa-eee	Investigative	73356106	C26H34N4O14	626.6	CC(=O)N[C@@H](CC1=CC(=C(C=C1)O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O	IC50 = 160000 nM	Poor binder
T85943	Proto-oncogene c-Src	BU0QC7	7-(3,5-Dimethoxyphenyl)-N-(2-methoxyphenyl)-5-methyl-1,2,4-benzotriazin-3-amine	Investigative	59837644	C23H22N4O3	402.4	CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=CC=C3OC)C4=CC(=CC(=C4)OC)OC	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BU98SY	1-[7-Amino-3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-yl]-3-tert-butylurea	Investigative	5328999	C21H25N5O3	395.5	CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=CC2=N1)N)C3=CC(=CC(=C3)OC)OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BUBK49	(1S)-2-(1H-Indol-3-YL)-1-[({5-[(E)-2-pyridin-4-ylvinyl]pyridin-3-YL}oxy)methyl]ethylamine	Investigative	6914613	C23H22N4O	370.4	C1=CC=C2C(=C1)C(=CN2)C[C@@H](COC3=CN=CC(=C3)/C=C/C4=CC=NC=C4)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BUC20J	1-(4-Bromophenyl)-2-(4-(4-(4-chlorobutyl)phenyl)-1H-1,2,3-triazol-1-yl)ethanone	Investigative	53318639	C20H19BrClN3O	432.7	C1=CC(=CC=C1CCCCCl)C2=CN(N=N2)CC(=O)C3=CC=C(C=C3)Br	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BUC60M	(E)-3-[6-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]quinolin-3-yl]prop-2-enamide	Investigative	46232511	C20H15Cl2FN2O2	405.2	CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=CC3=CC(=CN=C3C=C2)/C=C/C(=O)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BUD4J7	N-[4-Methyl-3-(4-thiophen-2-yl-pyrimidin-2-ylamino)-phenyl]-benzamide	Investigative	44273554	C22H18N4OS	386.5	CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2)NC3=NC=CC(=N3)C4=CC=CS4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BUD63Q	N-((1H-Indol-3-yl)(2,4-dimethoxyphenyl)methyl)-N-methylbenzenamine	Investigative	54583551	C24H24N2O2	372.5	CN(C1=CC=CC=C1)C(C2=C(C=C(C=C2)OC)OC)C3=CNC4=CC=CC=C43	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BUE21Z	1-[2-Amino-6-(3-ethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea	Investigative	5329131	C20H24N6O2	380.4	CCOC1=CC=CC(=C1)C2=C(N=C3C(=C2)C=NC(=N3)N)NC(=O)NC(C)(C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BUF0Q1	Methyl 2-[2-[(dimethylamino)methyl]-3-oxo-3-(4-phenylmethoxyphenyl)propyl]sulfanylbenzoate;hydrochloride	Investigative	45264620	C27H30ClNO4S	500	CN(C)CC(CSC1=CC=CC=C1C(=O)OC)C(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3.Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BUWB45	3-(3,4-Dichlorophenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-indazol-4-one	Investigative	57402053	C20H16Cl2N2O	371.3	CC1=CC=C(C=C1)N2C(=C3C(=N2)CCCC3=O)C4=CC(=C(C=C4)Cl)Cl	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BUZ08E	Dithiobis(1H-indole-3-carboxamide) deriv. 10v	Investigative	5328613	C34H30N4O2S2	590.8	CC1=C2C(=CC=C1)C(=C(N2C)SSC3=C(C4=CC=CC(=C4N3C)C)C(=O)NC5=CC=CC=C5)C(=O)NC6=CC=CC=C6	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BV8HO5	2-(2-Formyloxymethyl-4-methyl-phenyl)-malonic acid	Investigative	44316297	C12H12O6	252.22	CC1=CC(=C(C=C1)C(C(=O)O)C(=O)O)COC=O	IC50 = 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BVA43G	1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Naphthalen-1-Ylurea	Investigative	25174101	C24H25N5O	399.5	CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=CC=CC3=CC=CC=C32)C4=CC=CC(=C4)N	IC50 = 64100 nM	Poor binder
T85943	Proto-oncogene c-Src	BVDT10	5-Substituted 1-Phenylbenzimidazole 25	Investigative	5328515	C20H23N3OS	353.5	C1COCCN1CCCSC2=CC3=C(C=C2)N(C=N3)C4=CC=CC=C4	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BVG41B	3-(3,4-Dichlorophenyl)-6,6-dimethyl-2-thiophen-2-yl-5,7-dihydroindazol-4-one	Investigative	57403800	C19H16Cl2N2OS	391.3	CC1(CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CS4)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BVI90B	Chembl4276946	Investigative	134611886	C12H11Cl2N3O	284.14	CC1=NN(C(=C1C2=CC(=C(C=C2)Cl)Cl)N)C(=O)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BVI9T8	7-(2,6-Dimethylphenyl)-N-(2-methoxyphenyl)-5-methylbenzo[e][1,2,4]triazin-3-amine	Investigative	11603131	C23H22N4O	370.4	CC1=C(C(=CC=C1)C)C2=CC3=C(C(=C2)C)N=C(N=N3)NC4=CC=CC=C4OC	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BVM69H	5-Chloro-1-methyl-N-phenyl-2-sulfanylidene-3H-indole-3-carboxamide	Investigative	5328619	C16H13ClN2OS	316.8	CN1C2=C(C=C(C=C2)Cl)C(C1=S)C(=O)NC3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BVS35M	(18S)-18-[(Benzylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione	Investigative	10768554	C33H30N4O3	530.6	C1CN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO[C@@H]1CNCC6=CC=CC=C6)C7=CC=CC=C75)C(=O)NC4=O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BVW4K6	[4-[[(3R,6S,9R,12S,18S)-6-(2-Amino-2-oxoethyl)-2,5,8,11,14,17-hexaoxo-3,9-di(propan-2-yl)-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-12-yl]methyl]phenyl] dihydrogen phosphate	Investigative	44385824	C30H44N7O11P	709.7	CC(C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)NCC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)OP(=O)(O)O)C(C)C)CC(=O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BVWA26	3-(3,4-Dichlorophenyl)-2-(2-fluorophenyl)-6,7-dihydro-5H-indazol-4-one	Investigative	57400251	C19H13Cl2FN2O	375.2	C1CC2=NN(C(=C2C(=O)C1)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4F	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BW1NB3	1-(4-p-Tolyl-1H-1,2,3-triazol-1-yl)propan-2-one	Investigative	53323928	C12H13N3O	215.25	CC1=CC=C(C=C1)C2=CN(N=N2)CC(=O)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BW5T8S	3-(4-Tert-butylphenyl)-6,6-dimethyl-2-(4-methylphenyl)-5,7-dihydroindazol-4-one	Investigative	57395000	C26H30N2O	386.5	CC1=CC=C(C=C1)N2C(=C3C(=N2)CC(CC3=O)(C)C)C4=CC=C(C=C4)C(C)(C)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BW5Z8N	1,2,4-Oxadiazole Analogue 15c	Investigative	5329228	C32H31N4O8P	630.6	C1=CC=C(C=C1)CC(=O)N[C@@H](CC2=CC=C(C=C2)OP(=O)(O)O)C(=O)N[C@@H](CO)C3=NC(=NO3)CC4=CC5=CC=CC=C5C=C4	IC50 = 68000 nM	Poor binder
T85943	Proto-oncogene c-Src	BW9C2Z	8-Chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-({[1-(1-propylpiperidin-4-yl)-1H-1,2,3-triazol-4-yl]methyl}amino)quinoline-3-carbonitrile	Investigative	44143371	C27H27Cl2FN8	553.5	CCCN1CCC(CC1)N2C=C(N=N2)CNC3=CC4=C(C(=CN=C4C(=C3)Cl)C#N)NC5=CC(=C(C=C5)F)Cl	IC50 = 72000 nM	Poor binder
T85943	Proto-oncogene c-Src	BWC5O1	3-(4-Tert-butylphenyl)-2-(4-chlorophenyl)-6,6-dimethyl-[1,3]dioxino[4,5-c]pyrazol-4-one	Investigative	57398519	C23H23ClN2O3	410.9	CC1(OC2=NN(C(=C2C(=O)O1)C3=CC=C(C=C3)C(C)(C)C)C4=CC=C(C=C4)Cl)C	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BWM1Y9	3',8-Diamino-6-methoxyflavone	Investigative	10333957	C16H14N2O3	282.29	COC1=CC2=C(C(=C1)N)OC(=CC2=O)C3=CC(=CC=C3)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BWR50I	4-Fluoro-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	11338122	C22H16FN5O	385.4	C1=CC(=CC(=C1)NC(=O)C2=CC=C(C=C2)F)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BWX4G6	(3-Chloro-phenyl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine	Investigative	11737638	C15H11ClN4	282.73	C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CN=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BWYG21	9-Hydroxy-4-phenylpyrrolo[3,4-C]carbazole-1,3(2H,6H)-dione	Investigative	4369491	C20H12N2O3	328.3	C1=CC=C(C=C1)C2=CC3=C(C4=C(N3)C=CC(=C4)O)C5=C2C(=O)NC5=O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BX1VH9	N-(2,4-Dimethylphenyl)-7-(2,6-dimethylphenyl)-5-methylbenzo[e][1,2,4]triazin-3-amine	Investigative	11530772	C24H24N4	368.5	CC1=CC(=C(C=C1)NC2=NC3=C(C=C(C=C3C)C4=C(C=CC=C4C)C)N=N2)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BX62ZM	N-(2,5-Dimethylphenyl)-7-(2,6-dimethylphenyl)-5-methylbenzo[e][1,2,4]triazin-3-amine	Investigative	11581459	C24H24N4	368.5	CC1=CC(=C(C=C1)C)NC2=NC3=C(C=C(C=C3C)C4=C(C=CC=C4C)C)N=N2	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BX85FR	2-[4-(4-Methoxy-phenyl)-[1,2,3]triazol-1-yl]-1-phenylethanone	Investigative	46742603	C17H15N3O2	293.32	COC1=CC=C(C=C1)C(=O)CN2C=C(N=N2)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BX9V2P	1,2,4-Oxadiazole Analogue 5f	Investigative	6326464	C23H24F3N4O7P	556.4	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 72000 nM	Poor binder
T85943	Proto-oncogene c-Src	BXB01F	5-[4-Amino-1-(2,2-diethoxyethyl)pyrazolo[3,4-d]pyrimidin-3-yl]-1,3-benzoxazol-2-amine	Investigative	122163152	C18H21N7O3	383.4	CCOC(CN1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N)OCC	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BXOV01	1-(2-Amino-6-phenylpyrido[2,3-d]pyrimidin-7-yl)-3-tert-butylurea	Investigative	5329111	C18H20N6O	336.4	CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BXR75O	[4-[(2S)-3-[[(2S)-1-[[(2S)-4-Amino-1-[[(2S)-1-[(2S)-2-(butylcarbamoyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-oxo-2-(propanoylamino)propyl]phenyl] dihydrogen phosphate	Investigative	10629055	C35H56N7O11P	781.8	CCCCNC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)OP(=O)(O)O)NC(=O)CC	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BXSQ13	1-Methyl-2-[[1-methyl-3-(pyridin-4-ylcarbamoyl)indol-2-yl]disulfanyl]-N-pyridin-4-ylindole-3-carboxamide	Investigative	10053638	C30H24N6O2S2	564.7	CN1C2=CC=CC=C2C(=C1SSC3=C(C4=CC=CC=C4N3C)C(=O)NC5=CC=NC=C5)C(=O)NC6=CC=NC=C6	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BXZE35	(2S,3R)-2-[[(2S)-2-[[(4S)-4-[[(2S)-2-Amino-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoic acid	Investigative	56681809	C25H37N4O13P	632.6	CC[C@@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)N	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BY04GR	1-(4-Methylpiperazin-1-yl)propan-2-yl N-(3-bromophenyl)-N-[6-methylsulfanyl-1-(2-phenylpropyl)pyrazolo[3,4-d]pyrimidin-4-yl]carbamate	Investigative	121305843	C30H36BrN7O2S	638.6	CC(CN1C2=C(C=N1)C(=NC(=N2)SC)N(C3=CC(=CC=C3)Br)C(=O)OC(C)CN4CCN(CC4)C)C5=CC=CC=C5	Ki ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BY2B7J	6-Methyl-1-phenylbenzimidazol-5-ol	Investigative	5328529	C14H12N2O	224.26	CC1=CC2=C(C=C1O)N=CN2C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BY2EC5	1,2,4-Oxadiazole Analogue 4a	Investigative	5329214	C24H28N5O8P	545.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC(=O)N)C2=NC(=NO2)CC3=CC=CC=C3	IC50 = 72000 nM	Poor binder
T85943	Proto-oncogene c-Src	BY4D7N	(5,6-Dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-phenyl-amine	Investigative	13492269	C14H14N4	238.29	CC1=C(NC2=C1C(=NC=N2)NC3=CC=CC=C3)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BY7MP5	5-(1H-Indol-3-yl)-3-(3,4,5-trimethoxyphenyl)-1H-pyrazin-2-one	Investigative	118723185	C21H19N3O4	377.4	COC1=CC(=CC(=C1OC)OC)C2=NC(=CNC2=O)C3=CNC4=CC=CC=C43	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BY7TB4	5-Amino-3-pyridin-4-yl-1-(2,4,6-trichlorophenyl)pyrazole-4-carboxylic acid	Investigative	56950743	C15H9Cl3N4O2	383.6	C1=CN=CC=C1C2=NN(C(=C2C(=O)O)N)C3=C(C=C(C=C3Cl)Cl)Cl	IC50 = 55000 nM	Poor binder
T85943	Proto-oncogene c-Src	BY8Q3D	(3-Chloro-phenyl)-(6-methyl-5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine	Investigative	10616753	C19H15ClN4	334.8	CC1=C(C2=C(N1)N=CN=C2NC3=CC(=CC=C3)Cl)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BY8T1C	1-(4-Methoxyphenyl)-2-(4-m-tolyl-1H-1,2,3-triazol-1-yl)ethanone	Investigative	53317355	C18H17N3O2	307.3	CC1=CC(=CC=C1)C2=CN(N=N2)CC(=O)C3=CC=C(C=C3)OC	IC50 = 72800 nM	Poor binder
T85943	Proto-oncogene c-Src	BY9KT7	7-Phenyl-[1,3]dioxolo[4,5-f]benzimidazole	Investigative	5328527	C14H10N2O2	238.24	C1OC2=C(O1)C=C3C(=C2)N=CN3C4=CC=CC=C4	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BYFE32	{[4-((S)-2-Acetylamino-2-{(S)-1-[(3-cyclohexyl-propyl)-methyl-carbamoyl]-propylcarbamoyl}-ethyl)-phenyl]-difluoro-methyl}-phosphonic acid	Investigative	10076476	C26H40F2N3O6P	559.6	CC[C@@H](C(=O)N(C)CCCC1CCCCC1)NC(=O)[C@H](CC2=CC=C(C=C2)C(F)(F)P(=O)(O)O)NC(=O)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BYHM49	Ethyl 3-oxo-3-[[3-[5-(3-phenoxyprop-1-ynyl)thiophen-3-yl]-1,4-dihydroindeno[1,2-c]pyrazol-5-yl]amino]propanoate	Investigative	44440261	C28H23N3O4S	497.6	CCOC(=O)CC(=O)NC1=CC=CC2=C1CC3=C2NN=C3C4=CSC(=C4)C#CCOC5=CC=CC=C5	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BYJ2X1	3-[4-(3-Amino-7-methoxy-1,2-benzoxazol-4-yl)phenyl]-1-(2-fluoro-5-methylphenyl)urea	Investigative	11429654	C22H19FN4O3	406.4	CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=C(C=C3)OC)ON=C4N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BYO4R3	4',8-Diamino-6-hydroxyflavone	Investigative	11777791	C15H12N2O3	268.27	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=CC(=C3)O)N)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZ0YV3	2-(4-((4-Amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-1-(4-chlorophenyl)ethanone	Investigative	53317214	C22H17ClN8O	444.9	C1=CC=C(C=C1)C2=NN(C3=NC=NC(=C23)N)CC4=CN(N=N4)CC(=O)C5=CC=C(C=C5)Cl	IC50 ~ 75000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZ45VJ	3-[1-(1-Cyclopropylmethyl-piperidin-4-yl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-pyrrole-2,5-dione	Investigative	9826373	C30H30N4O2	478.6	CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7CC7	IC50 = 68000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZ8M5Y	N-((4-Hydroxy-3-bromophenyl)(1H-indol-3-yl)methyl)-N-methylbenzenamine	Investigative	54587466	C22H19BrN2O	407.3	CN(C1=CC=CC=C1)C(C2=CC(=C(C=C2)O)Br)C3=CNC4=CC=CC=C43	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZ9PR1	N-((1H-Indol-3-yl)(3-methoxyphenyl)methyl)-N-methylbenzenamine	Investigative	54581587	C23H22N2O	342.4	CN(C1=CC=CC=C1)C(C2=CC(=CC=C2)OC)C3=CNC4=CC=CC=C43	IC50 ~ 150000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZAD41	3-[[4-(3-Pyridinyl)-2-pyrimidinyl]amino]benzoic acid	Investigative	10039959	C16H12N4O2	292.29	C1=CC(=CC(=C1)NC2=NC=CC(=N2)C3=CN=CC=C3)C(=O)O	IC50 = 126000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZFN71	5-Hydroxy-7-methoxy-3-(3-chlorophenyl)quinoline-4(1H)-one	Investigative	10494548	C16H12ClNO3	301.72	COC1=CC2=C(C(=C1)O)C(=O)C(=CN2)C3=CC(=CC=C3)Cl	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZG5O9	3-Cyclohexyl-6,6-dimethyl-2-thiophen-2-yl-5,7-dihydroindazol-4-one	Investigative	57403738	C19H24N2OS	328.5	CC1(CC2=NN(C(=C2C(=O)C1)C3CCCCC3)C4=CC=CS4)C	IC50 = 77300 nM	Poor binder
T85943	Proto-oncogene c-Src	BZND97	(6-Methoxy-3-phenylbenzimidazol-5-yl)methanol	Investigative	5328533	C15H14N2O2	254.28	COC1=CC2=C(C=C1CO)N(C=N2)C3=CC=CC=C3	IC50 = 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZNF82	2-Methoxy-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide	Investigative	10136330	C24H21N5O2	411.5	CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2OC)NC3=NC=CC(=N3)C4=CN=CC=C4	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZOT67	4',5,7-Triamino-6-hydroxyflavone	Investigative	157820	C15H13N3O3	283.28	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3N)O)N)N	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZP20S	Rac-3-(6-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)quinolin-3-yl)-N,N-dimethylacrylamide	Investigative	46232513	C22H19Cl2FN2O2	433.3	CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=CC3=CC(=CN=C3C=C2)/C=C/C(=O)N(C)C	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	BZV4M2	(2S,3R)-2-[[(4S)-4-[[(2S)-2-[[(2S)-2-Acetamido-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoic acid	Investigative	56657888	C27H39N4O14P	674.6	CC[C@@H](C)[C@@H](C(=O)O)NC(=O)CC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C	IC50 = 80700 nM	Poor binder
T85943	Proto-oncogene c-Src	D00YCU	1-Phenyl-1H-benzoimidazol-5-ol	Investigative	667662	C13H10N2O	210.23	C1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	D01FWD	1-Phenyl-1H-benzoimidazole	Investigative	606669	C13H10N2	194.23	C1=CC=C(C=C1)N2C=NC3=CC=CC=C32	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	D01YWE	PMID19364658C33	Investigative	25207521	C17H14N4O4	338.32	C1=CC(=CC(=C1)O)C(C(=O)N)NC2=C(C(=O)C2=O)NC3=CC=NC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	D02XKJ	5-Methoxy-1-phenyl-1H-benzoimidazole	Investigative	5328466	C14H12N2O	224.26	COC1=CC2=C(C=C1)N(C=N2)C3=CC=CC=C3	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	D03MUZ	8-chloro-quinoline-3-carbonitrile	Investigative	17759555	C20H13Cl2FN6	427.3	C1=CC(=C(C=C1NC2=C3C=C(C=C(C3=NC=C2C#N)Cl)NCC4=CN=CN4)Cl)F	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	D06ZCX	LY-326449	Investigative	10455969	C26H23N3O4	441.5	C1CN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO[C@@H]1CO)C6=CC=CC=C65)C(=O)NC4=O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0C9KC	3-(3-Chloro-phenyl)-5,7-dihydroxy-chromen-4-one	Investigative	10850934	C15H9ClO4	288.68	C1=CC(=CC(=C1)Cl)C2=COC3=CC(=CC(=C3C2=O)O)O	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0D6DH	A-432411	Investigative	10125830	C20H16N2O3	332.4	COC1=C(C=CC(=C1)C2=CC3=C(C=C2)/C(=C/C4=CC=CN4)/C(=O)N3)O	IC50 ~ 50000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0EH6L	5,6-Bis-p-tolylamino-isoindole-1,3-dione	Investigative	10360970	C22H19N3O2	357.4	CC1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)C	IC50 ~ 100000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0EW3L	BUTEIN	Investigative	5281222	C15H12O5	272.25	C1=CC(=C(C=C1/C=C/C(=O)C2=C(C=C(C=C2)O)O)O)O	IC50 = 65000 nM	Poor binder
T85943	Proto-oncogene c-Src	D0K2YG	4-(5-Methoxy-benzoimidazol-1-yl)-phenylamine	Investigative	5328512	C14H13N3O	239.27	COC1=CC2=C(C=C1)N(C=N2)C3=CC=C(C=C3)N	IC50 ~ 50000 nM	Poor binder